{"gene":"CBX3","run_date":"2026-06-09T22:57:17","timeline":{"discoveries":[{"year":2005,"finding":"HP1γ (CBX3) is present in the transcribed region of all active genes examined in mammalian chromatin, and its presence there depends on elongation by RNA polymerase II, demonstrating a role for HP1γ in transcription elongation rather than solely in repression.","method":"Chromatin immunoprecipitation (ChIP) of HP1γ and H3K9 methylation marks at active gene bodies; RNA Pol II elongation inhibition experiments","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — ChIP at multiple active genes, elongation dependency established by Pol II inhibition, widely replicated in subsequent literature","pmids":["16061184"],"is_preprint":false},{"year":2007,"finding":"Suv39H1-mediated H3K9 trimethylation recruits HP1γ to the integrated HIV-1 LTR to establish chromatin-mediated transcriptional silencing and post-integration latency; HP1γ association is reversible and transcription-dependent, and HP1γ RNAi reactivates latent HIV-1.","method":"ChIP at HIV-1 LTR; siRNA knockdown of HP1γ with transcriptional reactivation readout; experiments in PBMCs from HIV-infected donors","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (ChIP, RNAi rescue, primary cells), validated in disease-relevant model","pmids":["17245432"],"is_preprint":false},{"year":2008,"finding":"On the HIV-1 LTR promoter, HP1β is present during transcriptional repression and is replaced by HP1γ upon activation; HP1γ localizes to both the promoter and coding region together with processive RNA Pol II, demonstrating an isoform-specific switch regulating transcriptional state.","method":"Sequential ChIP (ChIP-reChIP) at HIV-1 LTR at different transcriptional states; co-localization with Pol II CTD phosphorylation states","journal":"EMBO reports","confidence":"High","confidence_rationale":"Tier 2 / Moderate — reciprocal ChIP at distinct promoter states, two orthogonal methods (ChIP, Pol II phospho-state analysis), single lab","pmids":["18239689"],"is_preprint":false},{"year":2009,"finding":"HP1γ and cohesin are co-recruited to D4Z4 repeats in an H3K9me3-dependent and cell-type-specific manner; this recruitment is disrupted in FSHD, and cohesin plays an active role in HP1 recruitment at this locus.","method":"ChIP with D4Z4-specific primers in normal and FSHD patient cells and siRNA-treated cells; analysis of H3K9me3, HP1γ, and cohesin occupancy","journal":"PLoS genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — ChIP in patient cells and siRNA knockdown, replicated across normal and disease contexts, multiple marks assessed","pmids":["19593370"],"is_preprint":false},{"year":2010,"finding":"HP1γ (Cbx3) is required for male germ cell survival and spermatogenesis; hypomorphic Cbx3 mice show loss of germ cells (Sertoli cell-only phenotype) and derepression of L1 retrotransposons (ORF1p expression), establishing a non-redundant role in transposon silencing during spermatogenesis.","method":"Gene-targeted mouse (hypomorphic Cbx3 allele); histological analysis; immunostaining for L1 ORF1 protein","journal":"Epigenetics & chromatin","confidence":"High","confidence_rationale":"Tier 2 / Moderate — in vivo knockout model with defined phenotypic readouts, multiple histological and molecular endpoints, single lab","pmids":["20423503"],"is_preprint":false},{"year":2010,"finding":"JMJD2A/KDM4A and HP1γ antagonize each other during S phase: overexpression of HP1γ antagonizes JMJD2A-dependent S phase progression, and in C. elegans depletion of HPL-2 (HP1γ ortholog) rescues DNA replication defects caused by jmjd-2 loss, placing HP1γ as a conserved regulator of chromatin accessibility during DNA replication.","method":"Genetic epistasis in C. elegans (double mutants); mammalian cell overexpression/depletion with S phase progression assays; replication timing analysis","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic epistasis replicated in two organisms, S phase assays and replication timing measurements, multiple labs' precedents","pmids":["21145482"],"is_preprint":false},{"year":2010,"finding":"In embryonic stem cells, HP1γ depletion slows the cell cycle and decreases resistance to differentiation-inducing conditions, and impairs endoderm but not neurectoderm or mesoderm differentiation, establishing a role for HP1γ in ESC self-renewal and lineage choice.","method":"RNA interference in mouse ESCs; functional assays (proliferation, differentiation); RT-qPCR and microarray","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — clean RNAi with defined differentiation phenotype, single lab","pmids":["21085495"],"is_preprint":false},{"year":2011,"finding":"HP1γ facilitates inclusion of alternative exons (e.g., CD44 variable exons) by reducing RNA Pol II elongation rate; additionally, HP1γ stabilizes association of pre-mRNA with chromatin, acting as a bridge between H3K9me3-marked chromatin and the maturing mRNA to influence splicing decisions.","method":"siRNA knockdown of HP1γ with splicing assays; ChIP; RNA immunoprecipitation; Pol II elongation rate measurements","journal":"Nature structural & molecular biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (ChIP, RIP, splicing assays, Pol II analysis), mechanistic model tested with RNAi, well-cited","pmids":["21358630"],"is_preprint":false},{"year":2011,"finding":"HP1γ is required for meiotic synapsis in mice: Cbx3-deficient spermatocytes show impaired centromere clustering and synapsis; H3K9me2 at pericentric heterochromatin depends on Suv39h1-mediated H3K9me3 recognition by HP1γ, placing HP1γ downstream of Suv39h1 in a pathway with G9a for meiotic chromosome pairing.","method":"Cbx3-deficient mouse generation; comparative analysis with Suv39h1/h2- and G9a-deficient spermatocytes; immunofluorescence of meiotic chromosomes","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic epistasis in vivo across multiple knockout lines, defined meiotic phenotype, single lab with multiple controls","pmids":["21896631"],"is_preprint":false},{"year":2011,"finding":"HP1γ cooperates with histone variant H3.3 for heat-shock-induced HSP70 transcription: H3.3 knockdown prevents stable HP1γ recruitment to HSP70 promoters, and HP1γ knockdown reduces H3.3 levels at promoters; HP1γ selectively recognizes specific modification states of H3.3.","method":"siRNA knockdown of H3.3 or HP1γ; ChIP at HSP70 promoter; luciferase reporter assays","journal":"Nucleic acids research","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — reciprocal knockdowns with ChIP readout, single lab","pmids":["21742762"],"is_preprint":false},{"year":2012,"finding":"Genome-wide CBX3 binding at gene bodies correlates with transcriptional activity; CBX3 depletion causes accumulation of unspliced nascent transcripts and defective recruitment of splicing factors (SNRNP70), establishing a role for CBX3 in efficient co-transcriptional RNA processing.","method":"Genome-wide ChIP-seq (CBX3 localization); CBX3 knockdown with RNA-seq for nascent transcript analysis; ChIP for SNRNP70 recruitment","journal":"Genome research","confidence":"High","confidence_rationale":"Tier 2 / Strong — genome-wide ChIP-seq combined with nascent transcript analysis and splicing factor recruitment assays, mechanistically rigorous","pmids":["22684280"],"is_preprint":false},{"year":2012,"finding":"The Cbx3 chromodomain binds methylated histone H1K26me2 and G9aK185me3 with affinities comparable to H3K9me3; crystal structures of the human Cbx3 chromodomain in complex with H1K26me2 and G9aK185me3 peptides reveal a conserved binding mechanism, extending the binding repertoire of Cbx3 beyond H3K9me3.","method":"In vitro binding assays; X-ray crystallography of Cbx3 chromodomain–peptide complexes","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 1 / Moderate — crystal structures with in vitro binding quantification, two distinct complexes solved, single lab","pmids":["22514736"],"is_preprint":false},{"year":2012,"finding":"HP1γ interacts with BRCA1 and represses BRCA1-mediated transcription through modulation of promoter occupancy; BRCA1-HP1γ interaction (not methylated histone binding) is required for repression; after DNA damage, promoter-bound HP1γ is disassembled and BRCA1 is recruited, after which HP1γ/SUV39H1 are restored via BRCA1-HP1γ interaction to repress transcription in the recovery phase.","method":"Co-IP of HP1γ and BRCA1; ChIP time-lapse studies; HP1γ mutant analysis; siRNA for histone methyltransferases","journal":"Nucleic acids research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP, ChIP, and mutant analysis, multiple orthogonal methods, single lab","pmids":["23074186"],"is_preprint":false},{"year":2013,"finding":"Aurora A kinase phosphorylates HP1γ at serine 83 (Ser83) during G2/M phase; HP1γ knockdown causes mitotic aberrations that can be rescued by wild-type HP1γ but not by nonphosphorylatable S83A-HP1γ; the phosphomimetic S83D mutant increases DNA synthesis (EdU incorporation) while S83A abrogates it, establishing Aurora A–HP1γ as a mitotic pathway.","method":"Kinase assay; site-directed mutagenesis (S83A and S83D mutants); siRNA rescue experiments; EdU incorporation; genome-wide expression profiling","journal":"Epigenetics & chromatin","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro kinase assay with mutagenesis and phenotypic rescue, multiple orthogonal methods, single lab","pmids":["23829974"],"is_preprint":false},{"year":2014,"finding":"Shigella effector OspF (a phosphothreonine lyase) inactivates ERK and consequently MSK1, a novel HP1γ kinase that phosphorylates HP1γ at S83 within an MSK1-HP1γ complex; this blocks HP1γ accumulation on target genes and broadly reprograms host transcription including immune and proliferative genes.","method":"Identification of MSK1 as HP1γ kinase by Co-IP; phosphorylation assays; genome-wide transcriptome analysis; OspF mutant Shigella in guinea pig model","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 / Strong — Co-IP demonstrating MSK1-HP1γ complex, in vivo bacterial model, genome-wide transcriptome, multiple orthogonal approaches","pmids":["25216677"],"is_preprint":false},{"year":2015,"finding":"HP1γ binding to tri-methylated H3K9 in reconstituted tetranucleosomes requires nucleosome compaction (induced by Mg2+ or linker histone H1); the hinge region connecting the chromodomain and chromoshadow domain mediates this distinction from HP1α; HP1γ but not HP1α shows strongly enhanced selective binding under compacted nucleosome conditions.","method":"In vitro reconstituted tetranucleosome binding assays with HP1α and HP1γ; Mg2+/H1-induced compaction; hinge region mutant analysis","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 1 / Moderate — reconstituted nucleosome system, domain mutant analysis, in vitro mechanistic validation, single lab","pmids":["26319017"],"is_preprint":false},{"year":2017,"finding":"Cbx3 binds to gene promoters upon ESC-to-NPC differentiation and recruits Mediator subunit Med26; RNAi knockdown of either Cbx3 or Med26 inhibits neural differentiation and up-regulates mesodermal genes, establishing a Cbx3–Med26 axis that enforces neural lineage specification.","method":"ChIP at gene promoters; co-IP of Cbx3 and Med26; RNAi knockdown of Cbx3 and Med26 with lineage marker readouts","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 2 / Strong — Co-IP, ChIP, and RNAi rescue with defined differentiation phenotype, multiple orthogonal methods, single rigorous study","pmids":["28270516"],"is_preprint":false},{"year":2017,"finding":"HP1γ (CBX3) and its H3K9me-binding (chromodomain) activity are required for lung adenocarcinoma cell proliferation, colony formation, and migration; HP1γ directly represses NCOR2 and ZBTB7A transcription, which in turn limits expression of proto-oncogenic ELK1 and AXL.","method":"In vivo K-RasG12D mouse model with HP1γ depletion; ChIP for HP1γ at NCOR2 and ZBTB7A promoters; chromodomain mutants; rescue by NCOR2/ZBTB7A knockdown","journal":"Cancer research","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo mouse model, ChIP, chromodomain mutant, and genetic rescue experiments, multiple orthogonal methods","pmids":["29764865"],"is_preprint":false},{"year":2018,"finding":"Cbx3 inhibits VSMC proliferation and migration by transcriptionally repressing Notch3; luciferase assays show Notch signaling but not β-catenin or NF-κB is regulated by Cbx3; overexpression of Cbx3 in injured carotid arteries reduces Notch3 expression and neointima formation, while Notch3 reactivation reverses the effects of Cbx3.","method":"Cbx3 overexpression/knockdown in VSMCs; luciferase reporter assays for Notch3, β-catenin, NF-κB; carotid wire-injury mouse model with local Cbx3 delivery","journal":"Cardiovascular research","confidence":"High","confidence_rationale":"Tier 2 / Strong — luciferase assays, in vivo vascular injury model, genetic rescue with Notch3, multiple orthogonal methods","pmids":["29206900"],"is_preprint":false},{"year":2018,"finding":"CBX3 promotes aerobic glycolysis in pancreatic cancer cells by suppressing FBP1 expression; silencing FBP1 attenuates the decrease in glycolytic capacity caused by CBX3 knockdown, placing CBX3 upstream of FBP1 in a metabolic regulatory axis.","method":"CBX3 siRNA knockdown; glycolysis assays; FBP1 expression analysis; FBP1 rescue experiments","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — genetic epistasis via rescue experiment, single lab, limited mechanistic depth","pmids":["29678579"],"is_preprint":false},{"year":2019,"finding":"Peptidylarginine deiminase 4 (PAD4) citrullinates HP1γ at R38 and R39 within the chromodomain in mouse ESCs; this modification is enhanced by H3K9me3 peptides; citrullination (mimicked by R38/R39 mutations) reduces HP1γ binding to H3K9me3 peptides in vitro and decreases HP1γ residence time on chromatin in differentiating ESCs as measured by single-particle tracking.","method":"In vitro citrullination assay with PAD4; site-directed mutagenesis (R38/R39); peptide binding assays; live-cell single-particle tracking in mESCs","journal":"Epigenetics & chromatin","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro enzyme assay with mutagenesis and live-cell single-particle tracking, multiple orthogonal methods, single lab","pmids":["30940194"],"is_preprint":false},{"year":2020,"finding":"HPV E6 protein drives nuclear export of HP1γ through interaction between the NES sequence of HP1γ and exportin-1 (CRM-1); cytoplasmic HP1γ no longer suppresses UBE2L3, which then promotes E6-mediated p53 polyubiquitination and degradation; NES mutation retains HP1γ in the nucleus and reduces cervical cancer growth.","method":"Immunostaining showing cytoplasmic HP1γ in HPV+ cervical cancer; co-IP of HP1γ with exportin-1; leptomycin B nuclear retention; NES site-directed mutant; UBE2L3 expression assays; tumor xenograft","journal":"Cell death and differentiation","confidence":"High","confidence_rationale":"Tier 2 / Strong — co-IP, NES mutagenesis, pharmacological rescue, and in vivo xenograft, multiple orthogonal methods","pmids":["32203172"],"is_preprint":false},{"year":2020,"finding":"HP1γ, when nuclear, directly suppresses UBE2L3 expression; nuclear retention of HP1γ (by leptomycin B) or doxorubicin-induced DNA damage promotes HP1γ binding to the UBE2L3 promoter, stabilizes p53, and sensitizes cervical cancer cells to cisplatin.","method":"ChIP of HP1γ at UBE2L3 promoter; leptomycin B treatment; doxorubicin treatment; p53 stability assays","journal":"International journal of molecular sciences","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — ChIP and pharmacological perturbations, single lab, follow-up study to prior work","pmids":["32825184"],"is_preprint":false},{"year":2020,"finding":"Genic HP1γ colocalizes with and is required for H3K36me3 enrichment in ESCs; HP1γ-deleted ESCs show reduced H3K36me3 and decreased expression of shared target genes; the chromoshadow and hinge domains (not chromodomain H3K9me3 binding) are sufficient, because they retain interaction with NSD1, an H3K36 methyltransferase.","method":"HP1γ deletion in ESCs (ChIP-seq for H3K36me3 and H3K9me3); domain-swap/deletion mutants; Co-IP of HP1γ with NSD1","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 2 / Strong — ChIP-seq, domain mutant rescue, Co-IP of NSD1 interaction, multiple orthogonal methods, single rigorous study","pmids":["33237287"],"is_preprint":false},{"year":2021,"finding":"HP1γ binds hexameric RNA motifs and SINE-family transposable elements within introns via its RNA-binding activity; this tethers unspliced pre-mRNA to chromatin via intronic regions and limits usage of cryptic intronic splice sites, linking HP1γ RNA-binding to co-transcriptional splicing fidelity.","method":"RNA immunoprecipitation (RIP) followed by sequencing; identification of HP1γ-bound RNA motifs; genome-wide splicing analysis upon HP1γ loss","journal":"EMBO reports","confidence":"High","confidence_rationale":"Tier 2 / Moderate — RIP-seq with motif identification and genome-wide splicing analysis, single lab with multiple orthogonal approaches","pmids":["34312949"],"is_preprint":false},{"year":2021,"finding":"Cbx3/HP1γ deficiency in CD8+ T cells leads to chromatin remodeling and enhanced expression of Prf1, Gzmb, and Ifng; Cbx3-insufficient CD8+ T cells show increased NKG2D+ effector cells and reduced Treg infiltration in tumors, establishing Cbx3 as a regulator of CD8+ T cell effector differentiation.","method":"Cbx3-insufficient mouse model; gene expression analysis; tumor infiltrating lymphocyte flow cytometry; in vivo tumor experiments","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — in vivo mouse model with defined immune phenotype, single lab","pmids":["28220815"],"is_preprint":false},{"year":2021,"finding":"CBX3 forms a complex with TRIM28, TRIM24, and RBBP4 to repress ARHGAP24 expression, increasing active Rac1 levels in lung adenocarcinoma cells exposed to smoking-associated stimuli.","method":"Co-IP of CBX3 with TRIM28/TRIM24/RBBP4; ChIP at ARHGAP24 promoter; Rac1 activity assays; CBX3 knockdown/overexpression","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP and ChIP to identify complex and target, single lab","pmids":["34785774"],"is_preprint":false},{"year":2022,"finding":"CBX3 accelerates GBM progression by suppressing the E3 ligases PARK2 and STUB1 at the transcriptional level through its chromodomain (CD), reducing ubiquitination and degradation of EGFR; additionally, the chromoshadow domain (CSD) of CBX3 interacts with PARK2 protein and promotes its ubiquitination/degradation.","method":"CBX3 domain mutants (CD, CSD); Co-IP of CBX3 with PARK2; ChIP at PARK2/STUB1 promoters; ubiquitination assays; EGFR stability assays; erlotinib rescue","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP, ChIP, domain mutants and ubiquitination assays, single lab","pmids":["35459780"],"is_preprint":false},{"year":2023,"finding":"HDAC1-mediated deacetylation of HP1γ at lysine 5 in bortezomib-resistant myeloma cells reduces ubiquitin-mediated HP1γ degradation; deacetylated HP1γ interacts with MDC1 to enhance DNA repair and nuclear condensation, increasing chromatin accessibility at target genes (CD40, FOS, JUN) governing proteasome inhibitor sensitivity.","method":"SILAC-based acetyl-proteomics; site-specific mutagenesis of K5; Co-IP of HP1γ with MDC1; HDAC1 inhibitor rescue; ATAC-seq/chromatin accessibility; in vitro and in vivo bortezomib resistance models","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1 / Strong — proteomics-identified modification site, mutagenesis, Co-IP, chromatin accessibility assays, in vitro and in vivo rescue, multiple orthogonal methods","pmids":["36894562"],"is_preprint":false},{"year":2023,"finding":"CGRP induces anxiety behavior by promoting HP1γ phosphorylation (at a site linked to gene silencing) in the dorsal hippocampus, leading to HP1γ recruitment to the Klf11 enhancer (shown by ChIP), enhanced KLF11 expression, increased MAOB levels, and decreased dopamine.","method":"Intracerebroventricular/intra-hippocampal CGRP administration; ChIP for HP1γ at Klf11 enhancer; MAOB activity assays; dopamine measurement; behavioral tests","journal":"Communications biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP demonstrating HP1γ at Klf11 enhancer, pharmacological and siRNA interventions, in vivo model","pmids":["38503899"],"is_preprint":false},{"year":2023,"finding":"PLK1 phosphorylates CBX3 to enhance its interaction with RB1; this CBX3–RB1 interaction releases E2F1, modulating sensitivity to CDK4/6 inhibitors in CRPC; BRD4 transcriptionally upregulates CBX3 expression.","method":"Co-IP of CBX3 with RB1; PLK1 kinase assay; BRD4 inhibitor effects on CBX3 expression; CDK4/6 inhibitor sensitivity assays","journal":"Advanced science","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP and kinase context, multiple pathway perturbations, single lab","pmids":["37949681"],"is_preprint":false},{"year":2024,"finding":"CBX3 binds lactylated histone and recruits histone acetyltransferase EP300, increasing EP300 substrate specificity toward lactyl-CoA; this drives immunosuppressive transcriptional programs including CD47 upregulation. CBX3 does not possess direct lactyltransferase activity itself.","method":"Co-IP of CBX3 with EP300; lactyl-CoA substrate assays; CBX3 knockdown with transcriptional and phagocytosis readouts; in vitro and in vivo tumor models","journal":"The Journal of clinical investigation","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP identifying CBX3-EP300 interaction, substrate specificity assays, single lab","pmids":["39545414"],"is_preprint":false},{"year":2024,"finding":"CBX3 binds RPA2 and is recruited to stalled replication forks by RPA2; CBX3 inhibits RFWD3-facilitated replication restart; CK2 phosphorylates CBX3 at serine-95, augmenting CDH1-mediated CBX3 degradation and permitting RPA2 dynamics and fork restart; elevated CBX3 sensitizes prostate cancer cells to PARP inhibitors.","method":"Co-IP of CBX3 with RPA2; in vitro CK2 kinase assay; replication fork assays; CDH1-mediated degradation assays; PARP inhibitor sensitivity in CBX3-overexpressing cells","journal":"Science advances","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro kinase assay, Co-IP, replication fork restart assays, and PARP inhibitor functional readout, multiple orthogonal methods, single lab","pmids":["38781342"],"is_preprint":false},{"year":2024,"finding":"CBX3 (HP1γ) represses STAT1 and CD274 (PD-L1) by binding their promoters; IFNγ reduces CBX3 binding to these promoters; CBX3 deletion causes chronic colon inflammation with elevated STAT1 and PD-L1, and heightens CRC chemosensitivity under IFNγ stimulation.","method":"ChIP for CBX3 at STAT1 and CD274 promoters; CBX3 knockout mouse colon model; IFNγ treatment with CBX3 binding assays; in vivo syngeneic tumor model","journal":"EMBO molecular medicine","confidence":"High","confidence_rationale":"Tier 2 / Strong — ChIP, in vivo knockout, and syngeneic tumor model, multiple orthogonal methods","pmids":["38684864"],"is_preprint":false},{"year":2024,"finding":"CBX3 directly binds the promoter of CUL3, suppressing CUL3 transcription and CUL3-mediated NRF2 degradation, thereby upregulating NRF2 protein and downstream GPX2, inhibiting ferroptosis and promoting multidrug resistance in colorectal cancer.","method":"ChIP of CBX3 at CUL3 promoter; NRF2/CUL3/GPX2 protein expression assays; ferroptosis assays; PDX tumor models; ML385 NRF2 inhibitor","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP demonstrating CBX3 promoter binding, pathway rescue experiments, PDX model, single lab","pmids":["40089640"],"is_preprint":false},{"year":2025,"finding":"SETDB1-mediated H3K9me3 recruits CBX3 to the SIRT4 promoter to repress SIRT4 expression; SETDB1 knockdown upregulates SIRT4, decreases PTEN, promotes autophagy, and protects against renal I/R injury in vivo. Co-IP confirmed SETDB1–CBX3 interaction; sequential ChIP confirmed co-occupancy at the SIRT4 promoter.","method":"ChIP-reChIP and Co-IP for SETDB1 and CBX3 at SIRT4 promoter; SETDB1 knockdown in vivo rat I/R injury model; autophagy (TEM) and PTEN expression assays","journal":"FASEB journal","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — sequential ChIP and Co-IP, in vivo rat model, single lab","pmids":["40197868"],"is_preprint":false},{"year":2025,"finding":"The chromoshadow domain of HP1γ (HP1γCSD) interacts with the HP1 box of KAP1 and forms a dimer-of-dimers in an antiparallel arrangement (distinct from HP1αCSD parallel/concentration-dependent oligomerization); electrostatic interactions stabilize the HP1γCSD β-sheet interface, unlike the hydrophobic interface of HP1αCSD; in vivo rescue experiments in KAP1- and HP1-knockout ESCs demonstrate unique cooperative repression of lncRNA AI662270 by KAP1 and HP1γ but not other HP1s.","method":"X-ray crystallography; NMR; mass photometry of HP1γCSD-KAP1 Hbox complex; in vivo rescue in KAP1/HP1 knockout mESCs with lncRNA expression readout","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 1 / Strong — crystal structure, NMR, mass photometry, and in vivo genetic rescue, multiple orthogonal methods in single study","pmids":["41575850"],"is_preprint":false},{"year":2025,"finding":"TRIM66 interacts with HP1γ through a PxVxL motif; TRIM66–HP1γ co-undergoes liquid-liquid phase separation (LLPS) both in vitro and in vivo; the resulting condensates correlate with H3K9me3 sites and are associated with DNA damage response; HP1γ cannot phase-separate alone but does so cooperatively with TRIM66.","method":"Identification of PxVxL interaction; in vitro LLPS assay; in vivo condensate imaging; correlation with H3K9me3 by ChIP","journal":"Biophysics reports","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — in vitro reconstitution of LLPS, in vivo imaging, single lab without full mutagenesis validation","pmids":["40070663"],"is_preprint":false},{"year":2000,"finding":"HP1γ localizes to both euchromatin and heterochromatin compartments of interphase nuclei and to pericentromeric chromatin and arms of mitotic chromosomes; the amino-terminal epitope is selectively masked in non-replicative heterochromatin, explaining conflicting prior localizations; dual localization confirmed by GFP-HP1γ fusion.","method":"Immunocytochemistry with epitope-specific antibodies (N-terminal vs C-terminal); GFP-HP1γ fusion protein imaging; analysis across interphase and mitotic cells","journal":"Cytogenetics and cell genetics","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — direct localization by immunofluorescence and GFP fusion, two antibody approaches, single lab","pmids":["11124534"],"is_preprint":false},{"year":2017,"finding":"HP1γ is present in both the nucleus and cytoplasm; in the cytoplasm it co-localizes with and co-immunoprecipitates with actin (both G- and F-actin forms) in myoblasts; nuclear HP1γ–actin complex associates with the promoter and transcribed regions of GAPDH (re-ChIP); HP1γ knockdown impairs myoblast differentiation. Nuclear export is CRM-1-dependent (blocked by leptomycin B).","method":"Confocal and immunoelectron microscopy; cellular fractionation; Co-IP of HP1γ with actin (± cytochalasin D); re-ChIP at GAPDH; HP1γ knockdown differentiation assay; leptomycin B treatment","journal":"Biochimica et biophysica acta. Molecular cell research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple localization methods and Co-IP in multiple cell types, re-ChIP for nuclear complex, single lab","pmids":["29208528"],"is_preprint":false},{"year":2018,"finding":"NGF-PKA signaling in differentiating PC12 cells decreases HP1γ association with silent heterochromatin, phosphorylates HP1γ at S83 via PKA, and ultimately leads to HP1γ degradation; elevated HP1γ antagonizes neuronal differentiation while its loss facilitates it.","method":"NGF treatment of PC12 cells; PKA kinase assay; heterochromatin association assays; gain- and loss-of-function (overexpression and RNAi); genome-wide expression profiling","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — kinase assay identifying PKA-HP1γ S83 phosphorylation, genome-wide expression with functional rescue, single lab","pmids":["30305677"],"is_preprint":false},{"year":2023,"finding":"Loss of HP1γ in mouse embryonic fibroblasts downregulates TRF1 and other telomere-associated transcripts, increasing telomeric DNA-RNA hybrids (R-loops) and telomere replication stress (γH2AX), particularly on chromosomes 18 and X; this establishes a transcriptional control role for HP1γ in telomere maintenance.","method":"HP1γ-deficient MEFs; gene expression analysis; telomere FISH; immunofluorescence for γH2AX; DNA-RNA immunoprecipitation (DRIP)","journal":"Life sciences","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — mouse knockout cells, DRIP, FISH, single lab","pmids":["37598977"],"is_preprint":false},{"year":2018,"finding":"HP1γ deletion in cardiac myocytes does not affect H3K9me3 levels but significantly reduces H4K20me3 levels; HP1β protein is upregulated and redistributes to perinuclear heterochromatin in HP1γ KO cardiomyocytes; HP1γ is dispensable for cell cycle exit and normal cardiac growth.","method":"Conditional CM-specific HP1γ knockout mouse (Nkx2.5-Cre); echocardiography; ChIP/immunostaining for H3K9me3 and H4K20me3; global transcriptome analysis","journal":"Epigenetics & chromatin","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo conditional KO, chromatin mark analysis, transcriptomics, single lab","pmids":["29665845"],"is_preprint":false}],"current_model":"CBX3/HP1γ is a multifunctional chromatin reader that recognizes H3K9me2/3 (and also H1K26me2 and G9aK185me3) via its chromodomain; it associates with transcribed gene bodies to facilitate RNA Pol II elongation and co-transcriptional RNA processing/splicing via RNA-binding to intronic SINE elements; it undergoes isoform-specific phosphorylation (at S83 by MSK1 and Aurora A, and by PKA) and deacetylation (at K5 by HDAC1) that regulate its chromatin association, stability, and function; its chromoshadow domain mediates dimerization, KAP1 interaction (in an antiparallel dimer-of-dimers), recruitment of Med26 for lineage-specific transcription, NSD1-dependent H3K36me3 maintenance, and TRIM66-driven phase separation; it represses specific gene targets (STAT1/PD-L1, NCOR2/ZBTB7A, UBE2L3, CUL3, Notch3, SIRT4) through direct promoter binding; it plays non-redundant in vivo roles in spermatogenesis, meiotic synapsis, neural differentiation, CD8+ T cell effector function, and DNA replication fork restart (by binding RPA2 and being degraded via CK2-CDH1 to permit fork restart)."},"narrative":{"mechanistic_narrative":"CBX3/HP1γ is a chromodomain chromatin reader that, despite its HP1 heritage, functions broadly in transcriptional elongation, co-transcriptional RNA processing, and gene-specific repression by coupling histone-mark recognition to effector recruitment [PMID:16061184, PMID:22684280]. Its chromodomain recognizes H3K9me2/3 and, with comparable affinity, non-canonical methylated targets including H1K26me2 and G9aK185me3, defining an extended binding repertoire whose selectivity is tuned by nucleosome compaction and the hinge region that distinguishes HP1γ from HP1α [PMID:22514736, PMID:26319017]. At active genes HP1γ occupies transcribed bodies in an elongation-dependent manner [PMID:16061184], where it slows RNA Pol II to favor alternative-exon inclusion and, via direct RNA-binding to intronic SINE motifs, tethers nascent pre-mRNA to chromatin and recruits splicing factors to ensure co-transcriptional splicing fidelity [PMID:21358630, PMID:22684280, PMID:34312949]. Through its chromoshadow and hinge domains — independent of H3K9me3 reading — HP1γ partners with NSD1 to maintain genic H3K36me3, recruits the Mediator subunit Med26 to enforce neural lineage specification, and forms an antiparallel dimer-of-dimers with KAP1 for cooperative repression [PMID:28270516, PMID:33237287, PMID:41575850]. HP1γ is controlled by a dense layer of post-translational modification: S83 phosphorylation by Aurora A, MSK1, and PKA regulates its chromatin accumulation and mitotic/differentiation functions, K5 deacetylation by HDAC1 stabilizes it against ubiquitin-mediated degradation, and chromodomain citrullination by PAD4 lowers its H3K9me3 affinity and chromatin residence [PMID:23829974, PMID:25216677, PMID:30940194, PMID:36894562, PMID:30305677]. In vivo, HP1γ is non-redundantly required for spermatogenesis and meiotic synapsis downstream of Suv39h1, where it silences L1 retrotransposons, and it shapes ESC self-renewal and lineage choice [PMID:20423503, PMID:21896631, PMID:28270516]. It also acts at the replication and damage interface, binding RPA2 at stalled forks to restrain RFWD3-mediated restart until CK2-CDH1-driven degradation removes it [PMID:38781342]. As a sequence-specific repressor it directly binds and silences STAT1/PD-L1, NCOR2/ZBTB7A, UBE2L3, CUL3, Notch3, and SIRT4 promoters, linking it to anti-tumor immunity, vascular proliferation, ferroptosis resistance, and ischemic injury [PMID:29764865, PMID:29206900, PMID:32203172, PMID:38684864, PMID:40089640, PMID:40197868].","teleology":[{"year":2005,"claim":"Established that HP1γ is not solely a silencing factor but occupies transcribed bodies of active genes in an elongation-dependent way, overturning the purely repressive view of HP1 proteins.","evidence":"ChIP of HP1γ and H3K9 marks at active gene bodies with Pol II elongation inhibition in mammalian cells","pmids":["16061184"],"confidence":"High","gaps":["Did not define how HP1γ is targeted to active genes versus heterochromatin","No direct effector linking HP1γ occupancy to elongation machinery"]},{"year":2007,"claim":"Showed HP1γ can also execute heterochromatic silencing, being recruited by Suv39H1/H3K9me3 to establish reversible, transcription-dependent latency at the HIV-1 LTR.","evidence":"ChIP at HIV-1 LTR plus siRNA reactivation in PBMCs from infected donors","pmids":["17245432"],"confidence":"High","gaps":["Did not resolve how the same protein toggles between repressive and elongation-associated states"]},{"year":2008,"claim":"Resolved the dual-state paradox by demonstrating an HP1β-to-HP1γ isoform switch coupled to processive Pol II that converts a promoter from repressed to active.","evidence":"Sequential ChIP-reChIP at HIV-1 LTR across transcriptional states with Pol II CTD phospho-state analysis","pmids":["18239689"],"confidence":"High","gaps":["Mechanism driving the isoform exchange not identified","Generality beyond the LTR untested"]},{"year":2010,"claim":"Defined non-redundant in vivo roles, showing HP1γ is required for germ cell survival and transposon (L1) silencing during spermatogenesis and for ESC self-renewal and endoderm lineage choice.","evidence":"Hypomorphic Cbx3 mouse with histology and L1 ORF1p staining; RNAi in mouse ESCs with differentiation assays","pmids":["20423503","21085495"],"confidence":"High","gaps":["Molecular targets mediating germ-cell and lineage phenotypes not mapped","Lineage specificity (endoderm vs others) unexplained at the gene level"]},{"year":2011,"claim":"Connected HP1γ to co-transcriptional RNA processing and to meiotic chromosome organization, establishing both a splicing function and a heterochromatin-pairing pathway.","evidence":"RNAi/ChIP/RIP and Pol II elongation-rate assays for CD44 splicing; Cbx3-deficient spermatocytes compared with Suv39h1/G9a mutants by meiotic IF","pmids":["21358630","21896631","21742762"],"confidence":"High","gaps":["Direct RNA-binding determinant not yet identified in 2011","How splicing role relates to meiotic role unclear"]},{"year":2012,"claim":"Provided genome-wide and structural grounding: HP1γ gene-body occupancy scales with activity and is needed for splicing-factor recruitment, while crystallography revealed an extended chromodomain repertoire beyond H3K9me3.","evidence":"CBX3 ChIP-seq plus nascent RNA-seq and SNRNP70 ChIP; X-ray structures of the chromodomain with H1K26me2 and G9aK185me3; BRCA1 Co-IP/ChIP","pmids":["22684280","22514736","23074186"],"confidence":"High","gaps":["In vivo relevance of H1K26me2/G9aK185me3 binding not established","BRCA1-repression circuit based on single-lab Co-IP"]},{"year":2014,"claim":"Identified S83 phosphorylation as a master regulatory switch, with Aurora A (G2/M) and MSK1 (downstream of ERK) phosphorylating HP1γ to control its chromatin accumulation and downstream transcription.","evidence":"In vitro kinase assays with S83A/S83D mutants and rescue; MSK1-HP1γ Co-IP with OspF-Shigella in vivo model and transcriptome analysis","pmids":["23829974","25216677"],"confidence":"High","gaps":["How S83 phosphorylation mechanistically alters chromatin binding not resolved","Phosphatase counteracting S83 unknown"]},{"year":2015,"claim":"Defined the biophysical basis of HP1γ selectivity, showing its hinge region drives compaction-dependent H3K9me3 binding that distinguishes it from HP1α.","evidence":"Reconstituted tetranucleosome binding under Mg2+/H1 compaction with hinge mutants","pmids":["26319017"],"confidence":"High","gaps":["In vivo consequence of compaction selectivity not tested","Hinge interactors not identified"]},{"year":2017,"claim":"Separated reader-dependent from reader-independent functions: a Cbx3–Med26 axis enforces neural specification, while HP1γ chromodomain activity drives oncogenic repression of NCOR2/ZBTB7A in lung adenocarcinoma.","evidence":"Co-IP/ChIP/RNAi for Med26 in ESC-to-NPC differentiation; K-RasG12D mouse with chromodomain mutants and NCOR2/ZBTB7A rescue","pmids":["28270516","29764865"],"confidence":"High","gaps":["How Med26 recruitment is targeted to specific promoters unclear","Breadth of direct oncogenic targets incompletely mapped"]},{"year":2018,"claim":"Extended HP1γ repression to disease-relevant targets and tissues, repressing Notch3 in vascular smooth muscle and FBP1 in pancreatic cancer, while a cardiomyocyte knockout revealed selective H4K20me3 dependence and HP1β compensation.","evidence":"VSMC overexpression with luciferase and carotid injury model; CBX3/FBP1 glycolysis rescue; CM-specific HP1γ KO with chromatin-mark and transcriptome analysis; NGF-PKA S83 phosphorylation in PC12 cells","pmids":["29206900","29678579","29665845","30305677"],"confidence":"High","gaps":["Tissue-specific selection of repressed targets not explained","Compensation logic among HP1 isoforms not generalized"]},{"year":2019,"claim":"Added a reversible negative regulator of chromatin binding, showing PAD4 citrullinates the chromodomain at R38/R39 to reduce H3K9me3 affinity and chromatin residence during ESC differentiation.","evidence":"In vitro citrullination with R38/R39 mutants, peptide binding, and live-cell single-particle tracking in mESCs","pmids":["30940194"],"confidence":"High","gaps":["Genome-wide consequences of citrullination not mapped","Interplay with S83 phosphorylation untested"]},{"year":2020,"claim":"Linked HP1γ subcellular partitioning to tumor suppression, showing HPV E6/CRM-1-driven nuclear export relieves repression of UBE2L3 and destabilizes p53, while nuclear retention restores UBE2L3 silencing.","evidence":"Co-IP with exportin-1, NES mutagenesis, leptomycin B, ChIP at UBE2L3, and xenografts in cervical cancer cells","pmids":["32203172","32825184"],"confidence":"High","gaps":["Signals governing constitutive nucleocytoplasmic balance unclear","Cytoplasmic HP1γ functions beyond sequestration not defined"]},{"year":2021,"claim":"Established a reader-independent chromatin-maintenance role and RNA-based splicing mechanism: HP1γ maintains genic H3K36me3 via NSD1 through its CSD/hinge, and binds intronic SINE RNA to safeguard splice-site selection.","evidence":"ChIP-seq with domain mutants and NSD1 Co-IP in ESCs; RIP-seq with motif identification and splicing analysis; CD8+ T-cell and TRIM28/TRIM24/RBBP4 complex studies","pmids":["33237287","34312949","28220815","34785774"],"confidence":"High","gaps":["How RNA-binding and histone-reading activities are coordinated unresolved","Determinants of NSD1 versus other effector engagement unknown"]},{"year":2023,"claim":"Revealed acetylation-controlled stability and a direct role at replication forks, with HDAC1 K5 deacetylation protecting HP1γ from degradation and PLK1-enhanced RB1 binding modulating CDK4/6 sensitivity.","evidence":"SILAC acetyl-proteomics, K5 mutagenesis, MDC1 Co-IP and ATAC-seq in myeloma; PLK1 kinase/RB1 Co-IP in CRPC; HP1γ-deficient MEF telomere/R-loop analysis","pmids":["36894562","37949681","37598977"],"confidence":"High","gaps":["Crosstalk between K5 acetylation and S83/S95 phosphorylation not integrated","Telomere transcriptional control mechanism single-lab"]},{"year":2024,"claim":"Defined HP1γ control of replication-fork restart and immune/metabolic repression, with CK2-CDH1 degradation enabling fork restart and promoter binding silencing STAT1/PD-L1, CUL3, and lactylation/EP300-driven programs.","evidence":"RPA2 Co-IP, CK2 kinase, fork-restart and PARP-inhibitor assays; ChIP/KO mouse models for STAT1/CD274 and CUL3; CBX3-EP300 lactyl-CoA substrate assays","pmids":["38781342","38684864","40089640","39545414"],"confidence":"High","gaps":["Whether fork-restart and transcriptional roles share regulatory cues unclear","Direct versus indirect contribution to immune evasion targets not fully separated"]},{"year":2025,"claim":"Provided structural and biophysical mechanisms for HP1γ effector engagement, showing an antiparallel CSD dimer-of-dimers with KAP1 for unique cooperative repression and TRIM66-driven phase separation at H3K9me3.","evidence":"Crystallography/NMR/mass photometry of HP1γCSD-KAP1 with KO-ESC rescue; PxVxL/LLPS reconstitution with TRIM66; SETDB1-CBX3 ChIP-reChIP at SIRT4","pmids":["41575850","40070663","40197868"],"confidence":"High","gaps":["Functional output of TRIM66–HP1γ condensates in DNA damage not fully defined","How antiparallel CSD architecture dictates target specificity untested"]},{"year":null,"claim":"It remains unresolved how the many post-translational modifications (S83/S95 phosphorylation, K5 acetylation, R38/R39 citrullination) are integrated to coordinate HP1γ's parallel roles in elongation, splicing, repression, and fork restart, and what dictates target and isoform selection genome-wide.","evidence":"","pmids":[],"confidence":"High","gaps":["No unified model linking modification state to functional output","Genome-wide rules for direct repression-target selection unknown","Interplay between RNA-binding and histone-reading activities mechanistically undefined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0042393","term_label":"histone binding","supporting_discovery_ids":[0,11,15,20]},{"term_id":"GO:0003723","term_label":"RNA binding","supporting_discovery_ids":[7,24]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[17,18,33,34]},{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[16,23,36]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[0,38,39]},{"term_id":"GO:0005694","term_label":"chromosome","supporting_discovery_ids":[8,38]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[21,39]}],"pathway":[{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[0,10,33]},{"term_id":"R-HSA-8953854","term_label":"Metabolism of RNA","supporting_discovery_ids":[7,24]},{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[11,23,36]},{"term_id":"R-HSA-73894","term_label":"DNA Repair","supporting_discovery_ids":[28,32]},{"term_id":"R-HSA-1640170","term_label":"Cell Cycle","supporting_discovery_ids":[5,13]}],"complexes":["KAP1/TRIM28-HP1γ complex","TRIM28/TRIM24/RBBP4-CBX3 complex","MSK1-HP1γ complex"],"partners":["KAP1","NSD1","MED26","RPA2","MDC1","TRIM66","EP300","BRCA1"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q13185","full_name":"Chromobox protein homolog 3","aliases":["HECH","Heterochromatin protein 1 homolog gamma","HP1 gamma","Modifier 2 protein"],"length_aa":183,"mass_kda":20.8,"function":"Component of heterochromatin, which recognizes and binds histone H3 tails methylated at 'Lys-9', leading to epigenetic repression (PubMed:11242053). Also recognizes and binds histone H1.4 methylated at 'Lys-26' (H1.4K26me) (PubMed:16127177). Excluded from chromatin when histone H1.4 is Simultaneously methylated at Lys-26 (H1.4K26me) and phosphorylated at Ser-27 (H1.4S27Ph) (PubMed:16127177). Involved in the formation of functional kinetochore through interaction with MIS12 complex proteins (PubMed:15502821). Contributes to the conversion of local chromatin to a heterochromatin-like repressive state through H3 'Lys-9' trimethylation, mediates the recruitment of the methyltransferases SUV39H1 and/or SUV39H2 by the PER complex to the E-box elements of the circadian target genes such as PER2 itself or PER1 (By similarity). Mediates the recruitment of NIPBL to sites of DNA damage at double-strand breaks (DSBs) (PubMed:28167679)","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/Q13185/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/CBX3","classification":"Not Classified","n_dependent_lines":17,"n_total_lines":1208,"dependency_fraction":0.014072847682119206},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"CBX1","stoichiometry":10.0},{"gene":"H2AFZ","stoichiometry":10.0},{"gene":"SMARCA5","stoichiometry":10.0},{"gene":"HIST2H2BE","stoichiometry":4.0},{"gene":"HMGN5","stoichiometry":4.0},{"gene":"SSRP1","stoichiometry":4.0},{"gene":"TRIM28","stoichiometry":4.0},{"gene":"HMGA1","stoichiometry":0.2},{"gene":"MAP4K4","stoichiometry":0.2},{"gene":"MYO1E","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/CBX3","total_profiled":1310},"omim":[{"mim_id":"613198","title":"LYSINE METHYLTRANSFERASE 5C; KMT5C","url":"https://www.omim.org/entry/613198"},{"mim_id":"612000","title":"TRIPARTITE MOTIF-CONTAINING PROTEIN 66; TRIM66","url":"https://www.omim.org/entry/612000"},{"mim_id":"609174","title":"NSL1, MIS12 KINETOCHORE COMPLEX COMPONENT; NSL1","url":"https://www.omim.org/entry/609174"},{"mim_id":"609173","title":"KINETOCHORE SCAFFOLD 1; KNL1","url":"https://www.omim.org/entry/609173"},{"mim_id":"608802","title":"L3MBTL HISTONE METHYL-LYSINE-BINDING PROTEIN 1; L3MBTL1","url":"https://www.omim.org/entry/608802"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"},{"location":"Nuclear bodies","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/CBX3"},"hgnc":{"alias_symbol":["HP1Hs-gamma","HP1gamma"],"prev_symbol":[]},"alphafold":{"accession":"Q13185","domains":[{"cath_id":"2.40.50.40","chopping":"1-9_25-81","consensus_level":"medium","plddt":80.1164,"start":1,"end":81},{"cath_id":"2.40.50.40","chopping":"115-171","consensus_level":"medium","plddt":92.2312,"start":115,"end":171}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q13185","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q13185-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q13185-F1-predicted_aligned_error_v6.png","plddt_mean":75.38},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=CBX3","jax_strain_url":"https://www.jax.org/strain/search?query=CBX3"},"sequence":{"accession":"Q13185","fasta_url":"https://rest.uniprot.org/uniprotkb/Q13185.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q13185/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q13185"}},"corpus_meta":[{"pmid":"16061184","id":"PMC_16061184","title":"Histone H3 lysine 9 methylation and HP1gamma are associated with transcription elongation through mammalian chromatin.","date":"2005","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/16061184","citation_count":564,"is_preprint":false},{"pmid":"17245432","id":"PMC_17245432","title":"Suv39H1 and HP1gamma are responsible for chromatin-mediated HIV-1 transcriptional silencing and post-integration latency.","date":"2007","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/17245432","citation_count":265,"is_preprint":false},{"pmid":"19593370","id":"PMC_19593370","title":"Specific loss of histone H3 lysine 9 trimethylation and HP1gamma/cohesin binding at D4Z4 repeats is associated with facioscapulohumeral dystrophy (FSHD).","date":"2009","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19593370","citation_count":217,"is_preprint":false},{"pmid":"21358630","id":"PMC_21358630","title":"Histone H3 lysine 9 trimethylation and HP1γ favor inclusion of alternative exons.","date":"2011","source":"Nature structural & molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/21358630","citation_count":215,"is_preprint":false},{"pmid":"11124534","id":"PMC_11124534","title":"HP1gamma associates with euchromatin and heterochromatin in mammalian nuclei and chromosomes.","date":"2000","source":"Cytogenetics and cell genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11124534","citation_count":133,"is_preprint":false},{"pmid":"21145482","id":"PMC_21145482","title":"Conserved antagonism between JMJD2A/KDM4A and HP1γ during cell cycle progression.","date":"2010","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/21145482","citation_count":130,"is_preprint":false},{"pmid":"26333808","id":"PMC_26333808","title":"Heterochromatin protein HP1γ promotes colorectal cancer progression and is regulated by miR-30a.","date":"2015","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/26333808","citation_count":88,"is_preprint":false},{"pmid":"22684280","id":"PMC_22684280","title":"CBX3 regulates efficient RNA processing genome-wide.","date":"2012","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/22684280","citation_count":86,"is_preprint":false},{"pmid":"39545414","id":"PMC_39545414","title":"Lactate reprograms glioblastoma immunity through CBX3-regulated histone lactylation.","date":"2024","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/39545414","citation_count":85,"is_preprint":false},{"pmid":"22870217","id":"PMC_22870217","title":"Identification of CBX3 and ABCA5 as putative biomarkers for tumor stem cells in osteosarcoma.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22870217","citation_count":73,"is_preprint":false},{"pmid":"29764865","id":"PMC_29764865","title":"HP1γ Promotes Lung Adenocarcinoma by Downregulating the Transcription-Repressive Regulators NCOR2 and ZBTB7A.","date":"2018","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/29764865","citation_count":67,"is_preprint":false},{"pmid":"21896631","id":"PMC_21896631","title":"HP1γ links histone methylation marks to meiotic synapsis in mice.","date":"2011","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/21896631","citation_count":67,"is_preprint":false},{"pmid":"29678579","id":"PMC_29678579","title":"CBX3 promotes proliferation and regulates glycolysis via suppressing FBP1 in pancreatic cancer.","date":"2018","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/29678579","citation_count":51,"is_preprint":false},{"pmid":"20423503","id":"PMC_20423503","title":"HP1gamma function is required for male germ cell survival and spermatogenesis.","date":"2010","source":"Epigenetics & chromatin","url":"https://pubmed.ncbi.nlm.nih.gov/20423503","citation_count":50,"is_preprint":false},{"pmid":"33268783","id":"PMC_33268783","title":"LncRNA LINC00998 inhibits the malignant glioma phenotype via the CBX3-mediated c-Met/Akt/mTOR axis.","date":"2020","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/33268783","citation_count":50,"is_preprint":false},{"pmid":"18032920","id":"PMC_18032920","title":"Correlation of DNA methylation with histone modifications across the HNRPA2B1-CBX3 ubiquitously-acting chromatin open element (UCOE).","date":"2007","source":"Epigenetics","url":"https://pubmed.ncbi.nlm.nih.gov/18032920","citation_count":50,"is_preprint":false},{"pmid":"18618731","id":"PMC_18618731","title":"Identifying functional neighborhoods within the cell nucleus: proximity analysis of early S-phase replicating chromatin domains to sites of transcription, RNA polymerase II, HP1gamma, matrin 3 and SAF-A.","date":"2008","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18618731","citation_count":47,"is_preprint":false},{"pmid":"28193906","id":"PMC_28193906","title":"CBX3 promotes colon cancer cell proliferation by CDK6 kinase-independent function during cell cycle.","date":"2017","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/28193906","citation_count":45,"is_preprint":false},{"pmid":"29124886","id":"PMC_29124886","title":"CBX3/heterochromatin protein 1 gamma is significantly upregulated in patients with non-small cell lung cancer.","date":"2017","source":"Asia-Pacific journal of clinical oncology","url":"https://pubmed.ncbi.nlm.nih.gov/29124886","citation_count":44,"is_preprint":false},{"pmid":"18239689","id":"PMC_18239689","title":"Regulation of an inducible promoter by an HP1beta-HP1gamma switch.","date":"2008","source":"EMBO reports","url":"https://pubmed.ncbi.nlm.nih.gov/18239689","citation_count":44,"is_preprint":false},{"pmid":"23522301","id":"PMC_23522301","title":"HP1γ expression is elevated in prostate cancer and is superior to Gleason score as a predictor of biochemical recurrence after radical prostatectomy.","date":"2013","source":"BMC cancer","url":"https://pubmed.ncbi.nlm.nih.gov/23522301","citation_count":42,"is_preprint":false},{"pmid":"29206900","id":"PMC_29206900","title":"Cbx3 inhibits vascular smooth muscle cell proliferation, migration, and neointima formation.","date":"2018","source":"Cardiovascular research","url":"https://pubmed.ncbi.nlm.nih.gov/29206900","citation_count":37,"is_preprint":false},{"pmid":"28270516","id":"PMC_28270516","title":"Cbx3 maintains lineage specificity during neural differentiation.","date":"2017","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/28270516","citation_count":37,"is_preprint":false},{"pmid":"25216677","id":"PMC_25216677","title":"Shigella flexneri targets the HP1γ subcode through the phosphothreonine lyase OspF.","date":"2014","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/25216677","citation_count":37,"is_preprint":false},{"pmid":"21784059","id":"PMC_21784059","title":"Recruitment of the cohesin loading factor NIPBL to DNA double-strand breaks depends on MDC1, RNF168 and HP1γ in human cells.","date":"2011","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/21784059","citation_count":37,"is_preprint":false},{"pmid":"28967902","id":"PMC_28967902","title":"A regulatory circuit HP1γ/miR-451a/c-Myc promotes prostate cancer progression.","date":"2017","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/28967902","citation_count":35,"is_preprint":false},{"pmid":"35637952","id":"PMC_35637952","title":"CBX3 Regulated By YBX1 Promotes Smoking-induced Pancreatic Cancer Progression via Inhibiting SMURF2 Expression.","date":"2022","source":"International journal of biological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/35637952","citation_count":32,"is_preprint":false},{"pmid":"29903985","id":"PMC_29903985","title":"Overexpression of CBX3 in Pancreatic Adenocarcinoma Promotes Cell Cycle Transition-Associated Tumor Progression.","date":"2018","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/29903985","citation_count":32,"is_preprint":false},{"pmid":"12675308","id":"PMC_12675308","title":"HP1beta and HP1gamma, but not HP1alpha, decorate the entire XY body during human male meiosis.","date":"2003","source":"Chromosome research : an international journal on the molecular, supramolecular and evolutionary aspects of chromosome biology","url":"https://pubmed.ncbi.nlm.nih.gov/12675308","citation_count":31,"is_preprint":false},{"pmid":"33116867","id":"PMC_33116867","title":"CBX3 Promotes Gastric Cancer Progression and Affects Factors Related to Immunotherapeutic Responses.","date":"2020","source":"Cancer management and research","url":"https://pubmed.ncbi.nlm.nih.gov/33116867","citation_count":30,"is_preprint":false},{"pmid":"34785774","id":"PMC_34785774","title":"Smoking-associated upregulation of CBX3 suppresses ARHGAP24 expression to activate Rac1 signaling and promote tumor progression in lung adenocarcinoma.","date":"2021","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/34785774","citation_count":29,"is_preprint":false},{"pmid":"17900353","id":"PMC_17900353","title":"Ubiquitous expression of the rtTA2S-M2 inducible system in transgenic mice driven by the human hnRNPA2B1/CBX3 CpG island.","date":"2007","source":"BMC developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/17900353","citation_count":29,"is_preprint":false},{"pmid":"35459780","id":"PMC_35459780","title":"CBX3 accelerates the malignant progression of glioblastoma multiforme by stabilizing EGFR expression.","date":"2022","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/35459780","citation_count":28,"is_preprint":false},{"pmid":"32203172","id":"PMC_32203172","title":"HPV-mediated nuclear export of HP1γ drives cervical tumorigenesis by downregulation of p53.","date":"2020","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/32203172","citation_count":28,"is_preprint":false},{"pmid":"26319017","id":"PMC_26319017","title":"Nucleosome compaction facilitates HP1γ binding to methylated H3K9.","date":"2015","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/26319017","citation_count":28,"is_preprint":false},{"pmid":"33657224","id":"PMC_33657224","title":"LINC00857 contributes to proliferation and lymphomagenesis by regulating miR-370-3p/CBX3 axis in diffuse large B-cell lymphoma.","date":"2021","source":"Carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/33657224","citation_count":25,"is_preprint":false},{"pmid":"21742762","id":"PMC_21742762","title":"Histone variant H3.3 stimulates HSP70 transcription through cooperation with HP1γ.","date":"2011","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/21742762","citation_count":25,"is_preprint":false},{"pmid":"21085495","id":"PMC_21085495","title":"Role of the epigenetic regulator HP1γ in the control of embryonic stem cell properties.","date":"2010","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/21085495","citation_count":25,"is_preprint":false},{"pmid":"36894562","id":"PMC_36894562","title":"Deacetylation induced nuclear condensation of HP1γ promotes multiple myeloma drug resistance.","date":"2023","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/36894562","citation_count":24,"is_preprint":false},{"pmid":"38016610","id":"PMC_38016610","title":"m5C modification of LINC00324 promotes angiogenesis in glioma through CBX3/VEGFR2 pathway.","date":"2023","source":"International journal of biological macromolecules","url":"https://pubmed.ncbi.nlm.nih.gov/38016610","citation_count":24,"is_preprint":false},{"pmid":"23074186","id":"PMC_23074186","title":"Suppression and recovery of BRCA1-mediated transcription by HP1γ via modulation of promoter occupancy.","date":"2012","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/23074186","citation_count":22,"is_preprint":false},{"pmid":"22514736","id":"PMC_22514736","title":"Structural basis of the chromodomain of Cbx3 bound to methylated peptides from histone h1 and G9a.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22514736","citation_count":22,"is_preprint":false},{"pmid":"23829974","id":"PMC_23829974","title":"Functional impact of Aurora A-mediated phosphorylation of HP1γ at serine 83 during cell cycle progression.","date":"2013","source":"Epigenetics & chromatin","url":"https://pubmed.ncbi.nlm.nih.gov/23829974","citation_count":22,"is_preprint":false},{"pmid":"33459391","id":"PMC_33459391","title":"microRNA-377 acts as a suppressor in esophageal squamous cell carcinoma through CBX3-dependent P53/P21 pathway.","date":"2020","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/33459391","citation_count":21,"is_preprint":false},{"pmid":"33042419","id":"PMC_33042419","title":"lncRNA-SNHG17 promotes colon adenocarcinoma progression and serves as a sponge for miR-375 to regulate CBX3 expression.","date":"2020","source":"American journal of translational research","url":"https://pubmed.ncbi.nlm.nih.gov/33042419","citation_count":21,"is_preprint":false},{"pmid":"37949681","id":"PMC_37949681","title":"Targeting CBX3 with a Dual BET/PLK1 Inhibitor Enhances the Antitumor Efficacy of CDK4/6 Inhibitors in Prostate Cancer.","date":"2023","source":"Advanced science (Weinheim, Baden-Wurttemberg, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/37949681","citation_count":19,"is_preprint":false},{"pmid":"28220815","id":"PMC_28220815","title":"Cbx3/HP1γ deficiency confers enhanced tumor-killing capacity on CD8+ T cells.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/28220815","citation_count":18,"is_preprint":false},{"pmid":"30940194","id":"PMC_30940194","title":"Citrullination of HP1γ chromodomain affects association with chromatin.","date":"2019","source":"Epigenetics & chromatin","url":"https://pubmed.ncbi.nlm.nih.gov/30940194","citation_count":18,"is_preprint":false},{"pmid":"31669648","id":"PMC_31669648","title":"Circ-EZH2 knockdown reverses DDAH1 and CBX3-mediated cell growth and invasion in glioma through miR-1265 sponge activity.","date":"2019","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/31669648","citation_count":16,"is_preprint":false},{"pmid":"29665845","id":"PMC_29665845","title":"Deletion of HP1γ in cardiac myocytes affects H4K20me3 levels but does not impact cardiac growth.","date":"2018","source":"Epigenetics & chromatin","url":"https://pubmed.ncbi.nlm.nih.gov/29665845","citation_count":16,"is_preprint":false},{"pmid":"20695923","id":"PMC_20695923","title":"Heterochromatin marks HP1γ, HP1α and H3K9me3, and DNA damage response activation in human testis development and germ cell tumours.","date":"2010","source":"International journal of andrology","url":"https://pubmed.ncbi.nlm.nih.gov/20695923","citation_count":16,"is_preprint":false},{"pmid":"26680990","id":"PMC_26680990","title":"Evidence supporting a critical contribution of intrinsically disordered regions to the biochemical behavior of full-length human HP1γ.","date":"2015","source":"Journal of molecular modeling","url":"https://pubmed.ncbi.nlm.nih.gov/26680990","citation_count":16,"is_preprint":false},{"pmid":"37436074","id":"PMC_37436074","title":"PSMC4 promotes prostate carcinoma progression by regulating the CBX3-EGFR-PI3K-AKT-mTOR pathway.","date":"2023","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/37436074","citation_count":15,"is_preprint":false},{"pmid":"33781916","id":"PMC_33781916","title":"LINC01006 regulates the proliferation, migration and invasion of hepatocellular carcinoma cells through regulating miR-433-3p/CBX3 axis.","date":"2021","source":"Annals of hepatology","url":"https://pubmed.ncbi.nlm.nih.gov/33781916","citation_count":15,"is_preprint":false},{"pmid":"37674204","id":"PMC_37674204","title":"CBX3 promotes clear cell renal carcinoma through PI3K/AKT activation and aberrant immunity.","date":"2023","source":"Journal of translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/37674204","citation_count":14,"is_preprint":false},{"pmid":"34312949","id":"PMC_34312949","title":"HP1γ binding pre-mRNA intronic repeats modulates RNA splicing decisions.","date":"2021","source":"EMBO reports","url":"https://pubmed.ncbi.nlm.nih.gov/34312949","citation_count":14,"is_preprint":false},{"pmid":"34008749","id":"PMC_34008749","title":"lncRNA KCNQ1OT1 reverses the effect of sevoflurane on hepatocellular carcinoma progression via regulating the miR-29a-3p/CBX3 axis.","date":"2021","source":"Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas","url":"https://pubmed.ncbi.nlm.nih.gov/34008749","citation_count":14,"is_preprint":false},{"pmid":"40089640","id":"PMC_40089640","title":"CBX3 promotes multidrug resistance by suppressing ferroptosis in colorectal carcinoma via the CUL3/NRF2/GPX2 axis.","date":"2025","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/40089640","citation_count":13,"is_preprint":false},{"pmid":"38503899","id":"PMC_38503899","title":"CGRP causes anxiety via HP1γ-KLF11-MAOB pathway and dopamine in the dorsal hippocampus.","date":"2024","source":"Communications biology","url":"https://pubmed.ncbi.nlm.nih.gov/38503899","citation_count":13,"is_preprint":false},{"pmid":"11762190","id":"PMC_11762190","title":"The gene and pseudogenes of Cbx3/mHP1 gamma.","date":"2001","source":"DNA sequence : the journal of DNA sequencing and mapping","url":"https://pubmed.ncbi.nlm.nih.gov/11762190","citation_count":13,"is_preprint":false},{"pmid":"32825184","id":"PMC_32825184","title":"HP1γ Sensitizes Cervical Cancer Cells to Cisplatin through the Suppression of UBE2L3.","date":"2020","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/32825184","citation_count":13,"is_preprint":false},{"pmid":"34721405","id":"PMC_34721405","title":"Targeting Cbx3/HP1γ Induces LEF-1 and IL-21R to Promote Tumor-Infiltrating CD8 T-Cell Persistence.","date":"2021","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/34721405","citation_count":12,"is_preprint":false},{"pmid":"25441120","id":"PMC_25441120","title":"Up-regulation of HP1γ expression during neuronal maturation promotes axonal and dendritic development in mouse embryonic neocortex.","date":"2014","source":"Genes to cells : devoted to molecular & cellular mechanisms","url":"https://pubmed.ncbi.nlm.nih.gov/25441120","citation_count":12,"is_preprint":false},{"pmid":"33237287","id":"PMC_33237287","title":"HP1γ regulates H3K36 methylation and pluripotency in embryonic stem cells.","date":"2020","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/33237287","citation_count":11,"is_preprint":false},{"pmid":"37201048","id":"PMC_37201048","title":"NCAPG is transcriptionally regulated by CBX3 and activates the Wnt/β-catenin signaling pathway to promote proliferation and the cell cycle and inhibit apoptosis in colorectal cancer.","date":"2023","source":"Journal of gastrointestinal oncology","url":"https://pubmed.ncbi.nlm.nih.gov/37201048","citation_count":11,"is_preprint":false},{"pmid":"36818350","id":"PMC_36818350","title":"Inhibition of tiRNA-Gly-GCC ameliorates neointimal formation via CBX3-mediated VSMCs phenotypic switching.","date":"2023","source":"Frontiers in cardiovascular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/36818350","citation_count":11,"is_preprint":false},{"pmid":"31966547","id":"PMC_31966547","title":"MicroRNA-30b targets CBX3 and regulates cell proliferation, apoptosis, and migration in esophageal squamous cell carcinoma via the JAK2/STAT3 signaling pathway.","date":"2017","source":"International journal of clinical and experimental pathology","url":"https://pubmed.ncbi.nlm.nih.gov/31966547","citation_count":10,"is_preprint":false},{"pmid":"35471148","id":"PMC_35471148","title":"CBX3 regulated by miR-139 promotes the development of HCC by regulating cell cycle progression.","date":"2022","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/35471148","citation_count":9,"is_preprint":false},{"pmid":"29208528","id":"PMC_29208528","title":"Heterochromatin protein (HP)1γ is not only in the nucleus but also in the cytoplasm interacting with actin in both cell compartments.","date":"2017","source":"Biochimica et biophysica acta. Molecular cell research","url":"https://pubmed.ncbi.nlm.nih.gov/29208528","citation_count":9,"is_preprint":false},{"pmid":"28801671","id":"PMC_28801671","title":"The CpG-sites of the CBX3 ubiquitous chromatin opening element are critical structural determinants for the anti-silencing function.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/28801671","citation_count":9,"is_preprint":false},{"pmid":"23935992","id":"PMC_23935992","title":"A role for MeCP2 in switching gene activity via chromatin unfolding and HP1γ displacement.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23935992","citation_count":9,"is_preprint":false},{"pmid":"32971477","id":"PMC_32971477","title":"The role of the histones H3K9ac, H3K9me3, HP1γ, and H3K36me3 in oral squamous cell carcinoma loco-regional metastasis and relapse.","date":"2020","source":"Pathology, research and practice","url":"https://pubmed.ncbi.nlm.nih.gov/32971477","citation_count":8,"is_preprint":false},{"pmid":"33694060","id":"PMC_33694060","title":"The LncRNA RP11-279C4.1 Enhances the Malignant Behaviour of Glioma Cells and Glioma Stem-Like Cells by Regulating the miR-1273g-3p/CBX3 Axis.","date":"2021","source":"Molecular neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/33694060","citation_count":8,"is_preprint":false},{"pmid":"38684864","id":"PMC_38684864","title":"CBX3 antagonizes IFNγ/STAT1/PD-L1 axis to modulate colon inflammation and CRC chemosensitivity.","date":"2024","source":"EMBO molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/38684864","citation_count":7,"is_preprint":false},{"pmid":"35284119","id":"PMC_35284119","title":"CBX3 is associated with metastasis and glutathione/glycosphingolipid metabolism in colon adenocarcinoma.","date":"2022","source":"Journal of gastrointestinal oncology","url":"https://pubmed.ncbi.nlm.nih.gov/35284119","citation_count":7,"is_preprint":false},{"pmid":"35048461","id":"PMC_35048461","title":"Clinicopathological significance of CBX3 in colorectal cancer: An intensive expression study based on formalin-fixed and paraffin-embedded tissues.","date":"2022","source":"Pathology international","url":"https://pubmed.ncbi.nlm.nih.gov/35048461","citation_count":7,"is_preprint":false},{"pmid":"24971082","id":"PMC_24971082","title":"HP-1γ Controls High-Affinity Antibody Response to T-Dependent Antigens.","date":"2014","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/24971082","citation_count":7,"is_preprint":false},{"pmid":"38781342","id":"PMC_38781342","title":"CK2-dependent degradation of CBX3 dictates replication fork stalling and PARP inhibitor sensitivity.","date":"2024","source":"Science advances","url":"https://pubmed.ncbi.nlm.nih.gov/38781342","citation_count":6,"is_preprint":false},{"pmid":"40485707","id":"PMC_40485707","title":"The Prevalence and Characteristics of IgA Antibodies to β2-Spectrin and CBX3 in Immunoglobulin A Nephropathy.","date":"2025","source":"Kidney international reports","url":"https://pubmed.ncbi.nlm.nih.gov/40485707","citation_count":6,"is_preprint":false},{"pmid":"37633946","id":"PMC_37633946","title":"Co-amplification of CBX3 with EGFR or RAC1 in human cancers corroborated by a conserved genetic interaction among the genes.","date":"2023","source":"Cell death discovery","url":"https://pubmed.ncbi.nlm.nih.gov/37633946","citation_count":6,"is_preprint":false},{"pmid":"40197868","id":"PMC_40197868","title":"SETDB1 recruits CBX3 to regulate the SIRT4/PTEN axis, inhibiting autophagy and promoting ischemia-reperfusion-induced kidney injury.","date":"2025","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/40197868","citation_count":6,"is_preprint":false},{"pmid":"30305677","id":"PMC_30305677","title":"Mechanisms Underlying the Regulation of HP1γ by the NGF-PKA Signaling Pathway.","date":"2018","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/30305677","citation_count":6,"is_preprint":false},{"pmid":"25963260","id":"PMC_25963260","title":"A hypomorphic Cbx3 allele causes prenatal growth restriction and perinatal energy homeostasis defects.","date":"2015","source":"Journal of biosciences","url":"https://pubmed.ncbi.nlm.nih.gov/25963260","citation_count":6,"is_preprint":false},{"pmid":"39272883","id":"PMC_39272883","title":"Exploring the Role of CBX3 as a Potential Therapeutic Target in Lung Cancer.","date":"2024","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/39272883","citation_count":5,"is_preprint":false},{"pmid":"32027651","id":"PMC_32027651","title":"Discovery, expression, cellular localization, and molecular properties of a novel, alternative spliced HP1γ isoform, lacking the chromoshadow domain.","date":"2020","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/32027651","citation_count":5,"is_preprint":false},{"pmid":"37108510","id":"PMC_37108510","title":"HP1γ Prevents Activation of the cGAS/STING Pathway by Preserving Nuclear Envelope and Genomic Integrity in Colon Adenocarcinoma Cells.","date":"2023","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/37108510","citation_count":4,"is_preprint":false},{"pmid":"30386240","id":"PMC_30386240","title":"Chromatin Regulation by HP1γ Contributes to Survival of 5-Azacytidine-Resistant Cells.","date":"2018","source":"Frontiers in pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/30386240","citation_count":4,"is_preprint":false},{"pmid":"34077947","id":"PMC_34077947","title":"Qi Ling Inhibits Progression of Androgen-Independent Prostate Cancer via Negative Regulation of TRIM66/HP1γ/AR Axis.","date":"2021","source":"Complementary medicine research","url":"https://pubmed.ncbi.nlm.nih.gov/34077947","citation_count":4,"is_preprint":false},{"pmid":"40070663","id":"PMC_40070663","title":"TRIM66-HP1γ remodels the chromatin through phase separation.","date":"2025","source":"Biophysics reports","url":"https://pubmed.ncbi.nlm.nih.gov/40070663","citation_count":2,"is_preprint":false},{"pmid":"31476125","id":"PMC_31476125","title":"Role of Fine Structural Dynamics in Recognition of Histone H3 by HP1γ(CSD) Dimer and Ability of Force Fields to Describe Their Interaction Network.","date":"2019","source":"Journal of chemical theory and computation","url":"https://pubmed.ncbi.nlm.nih.gov/31476125","citation_count":2,"is_preprint":false},{"pmid":"41540451","id":"PMC_41540451","title":"CBX3 confers ferroptosis resistance during blood-borne metastasis.","date":"2026","source":"Journal of hematology & oncology","url":"https://pubmed.ncbi.nlm.nih.gov/41540451","citation_count":1,"is_preprint":false},{"pmid":"39934923","id":"PMC_39934923","title":"Induction of the p21/CDK6 pathway and alteration of the immune microenvironment by the stem cell marker CBX3 in melanoma.","date":"2025","source":"Stem cell research & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/39934923","citation_count":1,"is_preprint":false},{"pmid":"38646496","id":"PMC_38646496","title":"MicroRNA‑1224 inhibits cell proliferation by downregulating CBX3 expression in chordoma.","date":"2024","source":"Oncology letters","url":"https://pubmed.ncbi.nlm.nih.gov/38646496","citation_count":1,"is_preprint":false},{"pmid":"39601498","id":"PMC_39601498","title":"CBX3 Downregulates HLTF to Activate PI3K/AKT Signaling Promoting Cholangiocarcinoma.","date":"2024","source":"Advanced biology","url":"https://pubmed.ncbi.nlm.nih.gov/39601498","citation_count":1,"is_preprint":false},{"pmid":"37598977","id":"PMC_37598977","title":"Mouse HP1γ regulates TRF1 expression and telomere stability.","date":"2023","source":"Life sciences","url":"https://pubmed.ncbi.nlm.nih.gov/37598977","citation_count":0,"is_preprint":false},{"pmid":"40339498","id":"PMC_40339498","title":"lncRNA BBOX1-AS1 regulates the miR-382-5p/CBX3 Signalling pathway to affect the proliferation and apoptosis of glioblastoma cells.","date":"2025","source":"International immunopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/40339498","citation_count":0,"is_preprint":false},{"pmid":"41575850","id":"PMC_41575850","title":"HP1γ self-assembles and cooperates with KAP1 in repression of long noncoding RNA AI662270 in ESCs.","date":"2026","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/41575850","citation_count":0,"is_preprint":false},{"pmid":"39735331","id":"PMC_39735331","title":"CBX3 contributes to pancreatic adenocarcinoma progression via promoting KIF20A expression.","date":"2024","source":"Cytotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/39735331","citation_count":0,"is_preprint":false},{"pmid":"42004054","id":"PMC_42004054","title":"CBX3 promotes epithelial-mesenchymal transition in synovial sarcoma via the SHH signaling pathway.","date":"2026","source":"American journal of cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/42004054","citation_count":0,"is_preprint":false},{"pmid":"41218550","id":"PMC_41218550","title":"Clinical significance and molecular mechanism of CDX2-CBX3 regulatory axis in lung adenocarcinoma progression.","date":"2025","source":"Translational oncology","url":"https://pubmed.ncbi.nlm.nih.gov/41218550","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":49935,"output_tokens":10944,"usd":0.156982,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":22128,"output_tokens":6136,"usd":0.13202,"stage2_stop_reason":"end_turn"},"total_usd":0.289002,"stage1_batch_id":"msgbatch_01ACAxJQabDsht39JXeWG22d","stage2_batch_id":"msgbatch_01QEU22A9U5sbPTgsMzTmvSf","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2005,\n      \"finding\": \"HP1γ (CBX3) is present in the transcribed region of all active genes examined in mammalian chromatin, and its presence there depends on elongation by RNA polymerase II, demonstrating a role for HP1γ in transcription elongation rather than solely in repression.\",\n      \"method\": \"Chromatin immunoprecipitation (ChIP) of HP1γ and H3K9 methylation marks at active gene bodies; RNA Pol II elongation inhibition experiments\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — ChIP at multiple active genes, elongation dependency established by Pol II inhibition, widely replicated in subsequent literature\",\n      \"pmids\": [\"16061184\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Suv39H1-mediated H3K9 trimethylation recruits HP1γ to the integrated HIV-1 LTR to establish chromatin-mediated transcriptional silencing and post-integration latency; HP1γ association is reversible and transcription-dependent, and HP1γ RNAi reactivates latent HIV-1.\",\n      \"method\": \"ChIP at HIV-1 LTR; siRNA knockdown of HP1γ with transcriptional reactivation readout; experiments in PBMCs from HIV-infected donors\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (ChIP, RNAi rescue, primary cells), validated in disease-relevant model\",\n      \"pmids\": [\"17245432\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"On the HIV-1 LTR promoter, HP1β is present during transcriptional repression and is replaced by HP1γ upon activation; HP1γ localizes to both the promoter and coding region together with processive RNA Pol II, demonstrating an isoform-specific switch regulating transcriptional state.\",\n      \"method\": \"Sequential ChIP (ChIP-reChIP) at HIV-1 LTR at different transcriptional states; co-localization with Pol II CTD phosphorylation states\",\n      \"journal\": \"EMBO reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal ChIP at distinct promoter states, two orthogonal methods (ChIP, Pol II phospho-state analysis), single lab\",\n      \"pmids\": [\"18239689\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"HP1γ and cohesin are co-recruited to D4Z4 repeats in an H3K9me3-dependent and cell-type-specific manner; this recruitment is disrupted in FSHD, and cohesin plays an active role in HP1 recruitment at this locus.\",\n      \"method\": \"ChIP with D4Z4-specific primers in normal and FSHD patient cells and siRNA-treated cells; analysis of H3K9me3, HP1γ, and cohesin occupancy\",\n      \"journal\": \"PLoS genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — ChIP in patient cells and siRNA knockdown, replicated across normal and disease contexts, multiple marks assessed\",\n      \"pmids\": [\"19593370\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"HP1γ (Cbx3) is required for male germ cell survival and spermatogenesis; hypomorphic Cbx3 mice show loss of germ cells (Sertoli cell-only phenotype) and derepression of L1 retrotransposons (ORF1p expression), establishing a non-redundant role in transposon silencing during spermatogenesis.\",\n      \"method\": \"Gene-targeted mouse (hypomorphic Cbx3 allele); histological analysis; immunostaining for L1 ORF1 protein\",\n      \"journal\": \"Epigenetics & chromatin\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo knockout model with defined phenotypic readouts, multiple histological and molecular endpoints, single lab\",\n      \"pmids\": [\"20423503\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"JMJD2A/KDM4A and HP1γ antagonize each other during S phase: overexpression of HP1γ antagonizes JMJD2A-dependent S phase progression, and in C. elegans depletion of HPL-2 (HP1γ ortholog) rescues DNA replication defects caused by jmjd-2 loss, placing HP1γ as a conserved regulator of chromatin accessibility during DNA replication.\",\n      \"method\": \"Genetic epistasis in C. elegans (double mutants); mammalian cell overexpression/depletion with S phase progression assays; replication timing analysis\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic epistasis replicated in two organisms, S phase assays and replication timing measurements, multiple labs' precedents\",\n      \"pmids\": [\"21145482\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"In embryonic stem cells, HP1γ depletion slows the cell cycle and decreases resistance to differentiation-inducing conditions, and impairs endoderm but not neurectoderm or mesoderm differentiation, establishing a role for HP1γ in ESC self-renewal and lineage choice.\",\n      \"method\": \"RNA interference in mouse ESCs; functional assays (proliferation, differentiation); RT-qPCR and microarray\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — clean RNAi with defined differentiation phenotype, single lab\",\n      \"pmids\": [\"21085495\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"HP1γ facilitates inclusion of alternative exons (e.g., CD44 variable exons) by reducing RNA Pol II elongation rate; additionally, HP1γ stabilizes association of pre-mRNA with chromatin, acting as a bridge between H3K9me3-marked chromatin and the maturing mRNA to influence splicing decisions.\",\n      \"method\": \"siRNA knockdown of HP1γ with splicing assays; ChIP; RNA immunoprecipitation; Pol II elongation rate measurements\",\n      \"journal\": \"Nature structural & molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (ChIP, RIP, splicing assays, Pol II analysis), mechanistic model tested with RNAi, well-cited\",\n      \"pmids\": [\"21358630\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"HP1γ is required for meiotic synapsis in mice: Cbx3-deficient spermatocytes show impaired centromere clustering and synapsis; H3K9me2 at pericentric heterochromatin depends on Suv39h1-mediated H3K9me3 recognition by HP1γ, placing HP1γ downstream of Suv39h1 in a pathway with G9a for meiotic chromosome pairing.\",\n      \"method\": \"Cbx3-deficient mouse generation; comparative analysis with Suv39h1/h2- and G9a-deficient spermatocytes; immunofluorescence of meiotic chromosomes\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic epistasis in vivo across multiple knockout lines, defined meiotic phenotype, single lab with multiple controls\",\n      \"pmids\": [\"21896631\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"HP1γ cooperates with histone variant H3.3 for heat-shock-induced HSP70 transcription: H3.3 knockdown prevents stable HP1γ recruitment to HSP70 promoters, and HP1γ knockdown reduces H3.3 levels at promoters; HP1γ selectively recognizes specific modification states of H3.3.\",\n      \"method\": \"siRNA knockdown of H3.3 or HP1γ; ChIP at HSP70 promoter; luciferase reporter assays\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — reciprocal knockdowns with ChIP readout, single lab\",\n      \"pmids\": [\"21742762\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Genome-wide CBX3 binding at gene bodies correlates with transcriptional activity; CBX3 depletion causes accumulation of unspliced nascent transcripts and defective recruitment of splicing factors (SNRNP70), establishing a role for CBX3 in efficient co-transcriptional RNA processing.\",\n      \"method\": \"Genome-wide ChIP-seq (CBX3 localization); CBX3 knockdown with RNA-seq for nascent transcript analysis; ChIP for SNRNP70 recruitment\",\n      \"journal\": \"Genome research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genome-wide ChIP-seq combined with nascent transcript analysis and splicing factor recruitment assays, mechanistically rigorous\",\n      \"pmids\": [\"22684280\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"The Cbx3 chromodomain binds methylated histone H1K26me2 and G9aK185me3 with affinities comparable to H3K9me3; crystal structures of the human Cbx3 chromodomain in complex with H1K26me2 and G9aK185me3 peptides reveal a conserved binding mechanism, extending the binding repertoire of Cbx3 beyond H3K9me3.\",\n      \"method\": \"In vitro binding assays; X-ray crystallography of Cbx3 chromodomain–peptide complexes\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — crystal structures with in vitro binding quantification, two distinct complexes solved, single lab\",\n      \"pmids\": [\"22514736\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"HP1γ interacts with BRCA1 and represses BRCA1-mediated transcription through modulation of promoter occupancy; BRCA1-HP1γ interaction (not methylated histone binding) is required for repression; after DNA damage, promoter-bound HP1γ is disassembled and BRCA1 is recruited, after which HP1γ/SUV39H1 are restored via BRCA1-HP1γ interaction to repress transcription in the recovery phase.\",\n      \"method\": \"Co-IP of HP1γ and BRCA1; ChIP time-lapse studies; HP1γ mutant analysis; siRNA for histone methyltransferases\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP, ChIP, and mutant analysis, multiple orthogonal methods, single lab\",\n      \"pmids\": [\"23074186\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Aurora A kinase phosphorylates HP1γ at serine 83 (Ser83) during G2/M phase; HP1γ knockdown causes mitotic aberrations that can be rescued by wild-type HP1γ but not by nonphosphorylatable S83A-HP1γ; the phosphomimetic S83D mutant increases DNA synthesis (EdU incorporation) while S83A abrogates it, establishing Aurora A–HP1γ as a mitotic pathway.\",\n      \"method\": \"Kinase assay; site-directed mutagenesis (S83A and S83D mutants); siRNA rescue experiments; EdU incorporation; genome-wide expression profiling\",\n      \"journal\": \"Epigenetics & chromatin\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro kinase assay with mutagenesis and phenotypic rescue, multiple orthogonal methods, single lab\",\n      \"pmids\": [\"23829974\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Shigella effector OspF (a phosphothreonine lyase) inactivates ERK and consequently MSK1, a novel HP1γ kinase that phosphorylates HP1γ at S83 within an MSK1-HP1γ complex; this blocks HP1γ accumulation on target genes and broadly reprograms host transcription including immune and proliferative genes.\",\n      \"method\": \"Identification of MSK1 as HP1γ kinase by Co-IP; phosphorylation assays; genome-wide transcriptome analysis; OspF mutant Shigella in guinea pig model\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — Co-IP demonstrating MSK1-HP1γ complex, in vivo bacterial model, genome-wide transcriptome, multiple orthogonal approaches\",\n      \"pmids\": [\"25216677\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"HP1γ binding to tri-methylated H3K9 in reconstituted tetranucleosomes requires nucleosome compaction (induced by Mg2+ or linker histone H1); the hinge region connecting the chromodomain and chromoshadow domain mediates this distinction from HP1α; HP1γ but not HP1α shows strongly enhanced selective binding under compacted nucleosome conditions.\",\n      \"method\": \"In vitro reconstituted tetranucleosome binding assays with HP1α and HP1γ; Mg2+/H1-induced compaction; hinge region mutant analysis\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — reconstituted nucleosome system, domain mutant analysis, in vitro mechanistic validation, single lab\",\n      \"pmids\": [\"26319017\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Cbx3 binds to gene promoters upon ESC-to-NPC differentiation and recruits Mediator subunit Med26; RNAi knockdown of either Cbx3 or Med26 inhibits neural differentiation and up-regulates mesodermal genes, establishing a Cbx3–Med26 axis that enforces neural lineage specification.\",\n      \"method\": \"ChIP at gene promoters; co-IP of Cbx3 and Med26; RNAi knockdown of Cbx3 and Med26 with lineage marker readouts\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — Co-IP, ChIP, and RNAi rescue with defined differentiation phenotype, multiple orthogonal methods, single rigorous study\",\n      \"pmids\": [\"28270516\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"HP1γ (CBX3) and its H3K9me-binding (chromodomain) activity are required for lung adenocarcinoma cell proliferation, colony formation, and migration; HP1γ directly represses NCOR2 and ZBTB7A transcription, which in turn limits expression of proto-oncogenic ELK1 and AXL.\",\n      \"method\": \"In vivo K-RasG12D mouse model with HP1γ depletion; ChIP for HP1γ at NCOR2 and ZBTB7A promoters; chromodomain mutants; rescue by NCOR2/ZBTB7A knockdown\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo mouse model, ChIP, chromodomain mutant, and genetic rescue experiments, multiple orthogonal methods\",\n      \"pmids\": [\"29764865\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Cbx3 inhibits VSMC proliferation and migration by transcriptionally repressing Notch3; luciferase assays show Notch signaling but not β-catenin or NF-κB is regulated by Cbx3; overexpression of Cbx3 in injured carotid arteries reduces Notch3 expression and neointima formation, while Notch3 reactivation reverses the effects of Cbx3.\",\n      \"method\": \"Cbx3 overexpression/knockdown in VSMCs; luciferase reporter assays for Notch3, β-catenin, NF-κB; carotid wire-injury mouse model with local Cbx3 delivery\",\n      \"journal\": \"Cardiovascular research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — luciferase assays, in vivo vascular injury model, genetic rescue with Notch3, multiple orthogonal methods\",\n      \"pmids\": [\"29206900\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"CBX3 promotes aerobic glycolysis in pancreatic cancer cells by suppressing FBP1 expression; silencing FBP1 attenuates the decrease in glycolytic capacity caused by CBX3 knockdown, placing CBX3 upstream of FBP1 in a metabolic regulatory axis.\",\n      \"method\": \"CBX3 siRNA knockdown; glycolysis assays; FBP1 expression analysis; FBP1 rescue experiments\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — genetic epistasis via rescue experiment, single lab, limited mechanistic depth\",\n      \"pmids\": [\"29678579\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Peptidylarginine deiminase 4 (PAD4) citrullinates HP1γ at R38 and R39 within the chromodomain in mouse ESCs; this modification is enhanced by H3K9me3 peptides; citrullination (mimicked by R38/R39 mutations) reduces HP1γ binding to H3K9me3 peptides in vitro and decreases HP1γ residence time on chromatin in differentiating ESCs as measured by single-particle tracking.\",\n      \"method\": \"In vitro citrullination assay with PAD4; site-directed mutagenesis (R38/R39); peptide binding assays; live-cell single-particle tracking in mESCs\",\n      \"journal\": \"Epigenetics & chromatin\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro enzyme assay with mutagenesis and live-cell single-particle tracking, multiple orthogonal methods, single lab\",\n      \"pmids\": [\"30940194\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"HPV E6 protein drives nuclear export of HP1γ through interaction between the NES sequence of HP1γ and exportin-1 (CRM-1); cytoplasmic HP1γ no longer suppresses UBE2L3, which then promotes E6-mediated p53 polyubiquitination and degradation; NES mutation retains HP1γ in the nucleus and reduces cervical cancer growth.\",\n      \"method\": \"Immunostaining showing cytoplasmic HP1γ in HPV+ cervical cancer; co-IP of HP1γ with exportin-1; leptomycin B nuclear retention; NES site-directed mutant; UBE2L3 expression assays; tumor xenograft\",\n      \"journal\": \"Cell death and differentiation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — co-IP, NES mutagenesis, pharmacological rescue, and in vivo xenograft, multiple orthogonal methods\",\n      \"pmids\": [\"32203172\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"HP1γ, when nuclear, directly suppresses UBE2L3 expression; nuclear retention of HP1γ (by leptomycin B) or doxorubicin-induced DNA damage promotes HP1γ binding to the UBE2L3 promoter, stabilizes p53, and sensitizes cervical cancer cells to cisplatin.\",\n      \"method\": \"ChIP of HP1γ at UBE2L3 promoter; leptomycin B treatment; doxorubicin treatment; p53 stability assays\",\n      \"journal\": \"International journal of molecular sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — ChIP and pharmacological perturbations, single lab, follow-up study to prior work\",\n      \"pmids\": [\"32825184\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Genic HP1γ colocalizes with and is required for H3K36me3 enrichment in ESCs; HP1γ-deleted ESCs show reduced H3K36me3 and decreased expression of shared target genes; the chromoshadow and hinge domains (not chromodomain H3K9me3 binding) are sufficient, because they retain interaction with NSD1, an H3K36 methyltransferase.\",\n      \"method\": \"HP1γ deletion in ESCs (ChIP-seq for H3K36me3 and H3K9me3); domain-swap/deletion mutants; Co-IP of HP1γ with NSD1\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — ChIP-seq, domain mutant rescue, Co-IP of NSD1 interaction, multiple orthogonal methods, single rigorous study\",\n      \"pmids\": [\"33237287\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"HP1γ binds hexameric RNA motifs and SINE-family transposable elements within introns via its RNA-binding activity; this tethers unspliced pre-mRNA to chromatin via intronic regions and limits usage of cryptic intronic splice sites, linking HP1γ RNA-binding to co-transcriptional splicing fidelity.\",\n      \"method\": \"RNA immunoprecipitation (RIP) followed by sequencing; identification of HP1γ-bound RNA motifs; genome-wide splicing analysis upon HP1γ loss\",\n      \"journal\": \"EMBO reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — RIP-seq with motif identification and genome-wide splicing analysis, single lab with multiple orthogonal approaches\",\n      \"pmids\": [\"34312949\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Cbx3/HP1γ deficiency in CD8+ T cells leads to chromatin remodeling and enhanced expression of Prf1, Gzmb, and Ifng; Cbx3-insufficient CD8+ T cells show increased NKG2D+ effector cells and reduced Treg infiltration in tumors, establishing Cbx3 as a regulator of CD8+ T cell effector differentiation.\",\n      \"method\": \"Cbx3-insufficient mouse model; gene expression analysis; tumor infiltrating lymphocyte flow cytometry; in vivo tumor experiments\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — in vivo mouse model with defined immune phenotype, single lab\",\n      \"pmids\": [\"28220815\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"CBX3 forms a complex with TRIM28, TRIM24, and RBBP4 to repress ARHGAP24 expression, increasing active Rac1 levels in lung adenocarcinoma cells exposed to smoking-associated stimuli.\",\n      \"method\": \"Co-IP of CBX3 with TRIM28/TRIM24/RBBP4; ChIP at ARHGAP24 promoter; Rac1 activity assays; CBX3 knockdown/overexpression\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP and ChIP to identify complex and target, single lab\",\n      \"pmids\": [\"34785774\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"CBX3 accelerates GBM progression by suppressing the E3 ligases PARK2 and STUB1 at the transcriptional level through its chromodomain (CD), reducing ubiquitination and degradation of EGFR; additionally, the chromoshadow domain (CSD) of CBX3 interacts with PARK2 protein and promotes its ubiquitination/degradation.\",\n      \"method\": \"CBX3 domain mutants (CD, CSD); Co-IP of CBX3 with PARK2; ChIP at PARK2/STUB1 promoters; ubiquitination assays; EGFR stability assays; erlotinib rescue\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP, ChIP, domain mutants and ubiquitination assays, single lab\",\n      \"pmids\": [\"35459780\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"HDAC1-mediated deacetylation of HP1γ at lysine 5 in bortezomib-resistant myeloma cells reduces ubiquitin-mediated HP1γ degradation; deacetylated HP1γ interacts with MDC1 to enhance DNA repair and nuclear condensation, increasing chromatin accessibility at target genes (CD40, FOS, JUN) governing proteasome inhibitor sensitivity.\",\n      \"method\": \"SILAC-based acetyl-proteomics; site-specific mutagenesis of K5; Co-IP of HP1γ with MDC1; HDAC1 inhibitor rescue; ATAC-seq/chromatin accessibility; in vitro and in vivo bortezomib resistance models\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — proteomics-identified modification site, mutagenesis, Co-IP, chromatin accessibility assays, in vitro and in vivo rescue, multiple orthogonal methods\",\n      \"pmids\": [\"36894562\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"CGRP induces anxiety behavior by promoting HP1γ phosphorylation (at a site linked to gene silencing) in the dorsal hippocampus, leading to HP1γ recruitment to the Klf11 enhancer (shown by ChIP), enhanced KLF11 expression, increased MAOB levels, and decreased dopamine.\",\n      \"method\": \"Intracerebroventricular/intra-hippocampal CGRP administration; ChIP for HP1γ at Klf11 enhancer; MAOB activity assays; dopamine measurement; behavioral tests\",\n      \"journal\": \"Communications biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP demonstrating HP1γ at Klf11 enhancer, pharmacological and siRNA interventions, in vivo model\",\n      \"pmids\": [\"38503899\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"PLK1 phosphorylates CBX3 to enhance its interaction with RB1; this CBX3–RB1 interaction releases E2F1, modulating sensitivity to CDK4/6 inhibitors in CRPC; BRD4 transcriptionally upregulates CBX3 expression.\",\n      \"method\": \"Co-IP of CBX3 with RB1; PLK1 kinase assay; BRD4 inhibitor effects on CBX3 expression; CDK4/6 inhibitor sensitivity assays\",\n      \"journal\": \"Advanced science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP and kinase context, multiple pathway perturbations, single lab\",\n      \"pmids\": [\"37949681\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"CBX3 binds lactylated histone and recruits histone acetyltransferase EP300, increasing EP300 substrate specificity toward lactyl-CoA; this drives immunosuppressive transcriptional programs including CD47 upregulation. CBX3 does not possess direct lactyltransferase activity itself.\",\n      \"method\": \"Co-IP of CBX3 with EP300; lactyl-CoA substrate assays; CBX3 knockdown with transcriptional and phagocytosis readouts; in vitro and in vivo tumor models\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP identifying CBX3-EP300 interaction, substrate specificity assays, single lab\",\n      \"pmids\": [\"39545414\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"CBX3 binds RPA2 and is recruited to stalled replication forks by RPA2; CBX3 inhibits RFWD3-facilitated replication restart; CK2 phosphorylates CBX3 at serine-95, augmenting CDH1-mediated CBX3 degradation and permitting RPA2 dynamics and fork restart; elevated CBX3 sensitizes prostate cancer cells to PARP inhibitors.\",\n      \"method\": \"Co-IP of CBX3 with RPA2; in vitro CK2 kinase assay; replication fork assays; CDH1-mediated degradation assays; PARP inhibitor sensitivity in CBX3-overexpressing cells\",\n      \"journal\": \"Science advances\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro kinase assay, Co-IP, replication fork restart assays, and PARP inhibitor functional readout, multiple orthogonal methods, single lab\",\n      \"pmids\": [\"38781342\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"CBX3 (HP1γ) represses STAT1 and CD274 (PD-L1) by binding their promoters; IFNγ reduces CBX3 binding to these promoters; CBX3 deletion causes chronic colon inflammation with elevated STAT1 and PD-L1, and heightens CRC chemosensitivity under IFNγ stimulation.\",\n      \"method\": \"ChIP for CBX3 at STAT1 and CD274 promoters; CBX3 knockout mouse colon model; IFNγ treatment with CBX3 binding assays; in vivo syngeneic tumor model\",\n      \"journal\": \"EMBO molecular medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — ChIP, in vivo knockout, and syngeneic tumor model, multiple orthogonal methods\",\n      \"pmids\": [\"38684864\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"CBX3 directly binds the promoter of CUL3, suppressing CUL3 transcription and CUL3-mediated NRF2 degradation, thereby upregulating NRF2 protein and downstream GPX2, inhibiting ferroptosis and promoting multidrug resistance in colorectal cancer.\",\n      \"method\": \"ChIP of CBX3 at CUL3 promoter; NRF2/CUL3/GPX2 protein expression assays; ferroptosis assays; PDX tumor models; ML385 NRF2 inhibitor\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP demonstrating CBX3 promoter binding, pathway rescue experiments, PDX model, single lab\",\n      \"pmids\": [\"40089640\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"SETDB1-mediated H3K9me3 recruits CBX3 to the SIRT4 promoter to repress SIRT4 expression; SETDB1 knockdown upregulates SIRT4, decreases PTEN, promotes autophagy, and protects against renal I/R injury in vivo. Co-IP confirmed SETDB1–CBX3 interaction; sequential ChIP confirmed co-occupancy at the SIRT4 promoter.\",\n      \"method\": \"ChIP-reChIP and Co-IP for SETDB1 and CBX3 at SIRT4 promoter; SETDB1 knockdown in vivo rat I/R injury model; autophagy (TEM) and PTEN expression assays\",\n      \"journal\": \"FASEB journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — sequential ChIP and Co-IP, in vivo rat model, single lab\",\n      \"pmids\": [\"40197868\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"The chromoshadow domain of HP1γ (HP1γCSD) interacts with the HP1 box of KAP1 and forms a dimer-of-dimers in an antiparallel arrangement (distinct from HP1αCSD parallel/concentration-dependent oligomerization); electrostatic interactions stabilize the HP1γCSD β-sheet interface, unlike the hydrophobic interface of HP1αCSD; in vivo rescue experiments in KAP1- and HP1-knockout ESCs demonstrate unique cooperative repression of lncRNA AI662270 by KAP1 and HP1γ but not other HP1s.\",\n      \"method\": \"X-ray crystallography; NMR; mass photometry of HP1γCSD-KAP1 Hbox complex; in vivo rescue in KAP1/HP1 knockout mESCs with lncRNA expression readout\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — crystal structure, NMR, mass photometry, and in vivo genetic rescue, multiple orthogonal methods in single study\",\n      \"pmids\": [\"41575850\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"TRIM66 interacts with HP1γ through a PxVxL motif; TRIM66–HP1γ co-undergoes liquid-liquid phase separation (LLPS) both in vitro and in vivo; the resulting condensates correlate with H3K9me3 sites and are associated with DNA damage response; HP1γ cannot phase-separate alone but does so cooperatively with TRIM66.\",\n      \"method\": \"Identification of PxVxL interaction; in vitro LLPS assay; in vivo condensate imaging; correlation with H3K9me3 by ChIP\",\n      \"journal\": \"Biophysics reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — in vitro reconstitution of LLPS, in vivo imaging, single lab without full mutagenesis validation\",\n      \"pmids\": [\"40070663\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"HP1γ localizes to both euchromatin and heterochromatin compartments of interphase nuclei and to pericentromeric chromatin and arms of mitotic chromosomes; the amino-terminal epitope is selectively masked in non-replicative heterochromatin, explaining conflicting prior localizations; dual localization confirmed by GFP-HP1γ fusion.\",\n      \"method\": \"Immunocytochemistry with epitope-specific antibodies (N-terminal vs C-terminal); GFP-HP1γ fusion protein imaging; analysis across interphase and mitotic cells\",\n      \"journal\": \"Cytogenetics and cell genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — direct localization by immunofluorescence and GFP fusion, two antibody approaches, single lab\",\n      \"pmids\": [\"11124534\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"HP1γ is present in both the nucleus and cytoplasm; in the cytoplasm it co-localizes with and co-immunoprecipitates with actin (both G- and F-actin forms) in myoblasts; nuclear HP1γ–actin complex associates with the promoter and transcribed regions of GAPDH (re-ChIP); HP1γ knockdown impairs myoblast differentiation. Nuclear export is CRM-1-dependent (blocked by leptomycin B).\",\n      \"method\": \"Confocal and immunoelectron microscopy; cellular fractionation; Co-IP of HP1γ with actin (± cytochalasin D); re-ChIP at GAPDH; HP1γ knockdown differentiation assay; leptomycin B treatment\",\n      \"journal\": \"Biochimica et biophysica acta. Molecular cell research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple localization methods and Co-IP in multiple cell types, re-ChIP for nuclear complex, single lab\",\n      \"pmids\": [\"29208528\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"NGF-PKA signaling in differentiating PC12 cells decreases HP1γ association with silent heterochromatin, phosphorylates HP1γ at S83 via PKA, and ultimately leads to HP1γ degradation; elevated HP1γ antagonizes neuronal differentiation while its loss facilitates it.\",\n      \"method\": \"NGF treatment of PC12 cells; PKA kinase assay; heterochromatin association assays; gain- and loss-of-function (overexpression and RNAi); genome-wide expression profiling\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — kinase assay identifying PKA-HP1γ S83 phosphorylation, genome-wide expression with functional rescue, single lab\",\n      \"pmids\": [\"30305677\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Loss of HP1γ in mouse embryonic fibroblasts downregulates TRF1 and other telomere-associated transcripts, increasing telomeric DNA-RNA hybrids (R-loops) and telomere replication stress (γH2AX), particularly on chromosomes 18 and X; this establishes a transcriptional control role for HP1γ in telomere maintenance.\",\n      \"method\": \"HP1γ-deficient MEFs; gene expression analysis; telomere FISH; immunofluorescence for γH2AX; DNA-RNA immunoprecipitation (DRIP)\",\n      \"journal\": \"Life sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — mouse knockout cells, DRIP, FISH, single lab\",\n      \"pmids\": [\"37598977\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"HP1γ deletion in cardiac myocytes does not affect H3K9me3 levels but significantly reduces H4K20me3 levels; HP1β protein is upregulated and redistributes to perinuclear heterochromatin in HP1γ KO cardiomyocytes; HP1γ is dispensable for cell cycle exit and normal cardiac growth.\",\n      \"method\": \"Conditional CM-specific HP1γ knockout mouse (Nkx2.5-Cre); echocardiography; ChIP/immunostaining for H3K9me3 and H4K20me3; global transcriptome analysis\",\n      \"journal\": \"Epigenetics & chromatin\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo conditional KO, chromatin mark analysis, transcriptomics, single lab\",\n      \"pmids\": [\"29665845\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"CBX3/HP1γ is a multifunctional chromatin reader that recognizes H3K9me2/3 (and also H1K26me2 and G9aK185me3) via its chromodomain; it associates with transcribed gene bodies to facilitate RNA Pol II elongation and co-transcriptional RNA processing/splicing via RNA-binding to intronic SINE elements; it undergoes isoform-specific phosphorylation (at S83 by MSK1 and Aurora A, and by PKA) and deacetylation (at K5 by HDAC1) that regulate its chromatin association, stability, and function; its chromoshadow domain mediates dimerization, KAP1 interaction (in an antiparallel dimer-of-dimers), recruitment of Med26 for lineage-specific transcription, NSD1-dependent H3K36me3 maintenance, and TRIM66-driven phase separation; it represses specific gene targets (STAT1/PD-L1, NCOR2/ZBTB7A, UBE2L3, CUL3, Notch3, SIRT4) through direct promoter binding; it plays non-redundant in vivo roles in spermatogenesis, meiotic synapsis, neural differentiation, CD8+ T cell effector function, and DNA replication fork restart (by binding RPA2 and being degraded via CK2-CDH1 to permit fork restart).\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"CBX3/HP1\\u03b3 is a chromodomain chromatin reader that, despite its HP1 heritage, functions broadly in transcriptional elongation, co-transcriptional RNA processing, and gene-specific repression by coupling histone-mark recognition to effector recruitment [#0, #10]. Its chromodomain recognizes H3K9me2/3 and, with comparable affinity, non-canonical methylated targets including H1K26me2 and G9aK185me3, defining an extended binding repertoire whose selectivity is tuned by nucleosome compaction and the hinge region that distinguishes HP1\\u03b3 from HP1\\u03b1 [#11, #15]. At active genes HP1\\u03b3 occupies transcribed bodies in an elongation-dependent manner [#0], where it slows RNA Pol II to favor alternative-exon inclusion and, via direct RNA-binding to intronic SINE motifs, tethers nascent pre-mRNA to chromatin and recruits splicing factors to ensure co-transcriptional splicing fidelity [#7, #10, #24]. Through its chromoshadow and hinge domains \\u2014 independent of H3K9me3 reading \\u2014 HP1\\u03b3 partners with NSD1 to maintain genic H3K36me3, recruits the Mediator subunit Med26 to enforce neural lineage specification, and forms an antiparallel dimer-of-dimers with KAP1 for cooperative repression [#16, #23, #36]. HP1\\u03b3 is controlled by a dense layer of post-translational modification: S83 phosphorylation by Aurora A, MSK1, and PKA regulates its chromatin accumulation and mitotic/differentiation functions, K5 deacetylation by HDAC1 stabilizes it against ubiquitin-mediated degradation, and chromodomain citrullination by PAD4 lowers its H3K9me3 affinity and chromatin residence [#13, #14, #20, #28, #40]. In vivo, HP1\\u03b3 is non-redundantly required for spermatogenesis and meiotic synapsis downstream of Suv39h1, where it silences L1 retrotransposons, and it shapes ESC self-renewal and lineage choice [#4, #8, #16]. It also acts at the replication and damage interface, binding RPA2 at stalled forks to restrain RFWD3-mediated restart until CK2-CDH1-driven degradation removes it [#32]. As a sequence-specific repressor it directly binds and silences STAT1/PD-L1, NCOR2/ZBTB7A, UBE2L3, CUL3, Notch3, and SIRT4 promoters, linking it to anti-tumor immunity, vascular proliferation, ferroptosis resistance, and ischemic injury [#17, #18, #21, #33, #34, #35].\",\n  \"teleology\": [\n    {\n      \"year\": 2005,\n      \"claim\": \"Established that HP1\\u03b3 is not solely a silencing factor but occupies transcribed bodies of active genes in an elongation-dependent way, overturning the purely repressive view of HP1 proteins.\",\n      \"evidence\": \"ChIP of HP1\\u03b3 and H3K9 marks at active gene bodies with Pol II elongation inhibition in mammalian cells\",\n      \"pmids\": [\"16061184\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not define how HP1\\u03b3 is targeted to active genes versus heterochromatin\", \"No direct effector linking HP1\\u03b3 occupancy to elongation machinery\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Showed HP1\\u03b3 can also execute heterochromatic silencing, being recruited by Suv39H1/H3K9me3 to establish reversible, transcription-dependent latency at the HIV-1 LTR.\",\n      \"evidence\": \"ChIP at HIV-1 LTR plus siRNA reactivation in PBMCs from infected donors\",\n      \"pmids\": [\"17245432\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not resolve how the same protein toggles between repressive and elongation-associated states\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Resolved the dual-state paradox by demonstrating an HP1\\u03b2-to-HP1\\u03b3 isoform switch coupled to processive Pol II that converts a promoter from repressed to active.\",\n      \"evidence\": \"Sequential ChIP-reChIP at HIV-1 LTR across transcriptional states with Pol II CTD phospho-state analysis\",\n      \"pmids\": [\"18239689\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism driving the isoform exchange not identified\", \"Generality beyond the LTR untested\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Defined non-redundant in vivo roles, showing HP1\\u03b3 is required for germ cell survival and transposon (L1) silencing during spermatogenesis and for ESC self-renewal and endoderm lineage choice.\",\n      \"evidence\": \"Hypomorphic Cbx3 mouse with histology and L1 ORF1p staining; RNAi in mouse ESCs with differentiation assays\",\n      \"pmids\": [\"20423503\", \"21085495\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular targets mediating germ-cell and lineage phenotypes not mapped\", \"Lineage specificity (endoderm vs others) unexplained at the gene level\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Connected HP1\\u03b3 to co-transcriptional RNA processing and to meiotic chromosome organization, establishing both a splicing function and a heterochromatin-pairing pathway.\",\n      \"evidence\": \"RNAi/ChIP/RIP and Pol II elongation-rate assays for CD44 splicing; Cbx3-deficient spermatocytes compared with Suv39h1/G9a mutants by meiotic IF\",\n      \"pmids\": [\"21358630\", \"21896631\", \"21742762\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct RNA-binding determinant not yet identified in 2011\", \"How splicing role relates to meiotic role unclear\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Provided genome-wide and structural grounding: HP1\\u03b3 gene-body occupancy scales with activity and is needed for splicing-factor recruitment, while crystallography revealed an extended chromodomain repertoire beyond H3K9me3.\",\n      \"evidence\": \"CBX3 ChIP-seq plus nascent RNA-seq and SNRNP70 ChIP; X-ray structures of the chromodomain with H1K26me2 and G9aK185me3; BRCA1 Co-IP/ChIP\",\n      \"pmids\": [\"22684280\", \"22514736\", \"23074186\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo relevance of H1K26me2/G9aK185me3 binding not established\", \"BRCA1-repression circuit based on single-lab Co-IP\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Identified S83 phosphorylation as a master regulatory switch, with Aurora A (G2/M) and MSK1 (downstream of ERK) phosphorylating HP1\\u03b3 to control its chromatin accumulation and downstream transcription.\",\n      \"evidence\": \"In vitro kinase assays with S83A/S83D mutants and rescue; MSK1-HP1\\u03b3 Co-IP with OspF-Shigella in vivo model and transcriptome analysis\",\n      \"pmids\": [\"23829974\", \"25216677\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How S83 phosphorylation mechanistically alters chromatin binding not resolved\", \"Phosphatase counteracting S83 unknown\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Defined the biophysical basis of HP1\\u03b3 selectivity, showing its hinge region drives compaction-dependent H3K9me3 binding that distinguishes it from HP1\\u03b1.\",\n      \"evidence\": \"Reconstituted tetranucleosome binding under Mg2+/H1 compaction with hinge mutants\",\n      \"pmids\": [\"26319017\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo consequence of compaction selectivity not tested\", \"Hinge interactors not identified\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Separated reader-dependent from reader-independent functions: a Cbx3\\u2013Med26 axis enforces neural specification, while HP1\\u03b3 chromodomain activity drives oncogenic repression of NCOR2/ZBTB7A in lung adenocarcinoma.\",\n      \"evidence\": \"Co-IP/ChIP/RNAi for Med26 in ESC-to-NPC differentiation; K-RasG12D mouse with chromodomain mutants and NCOR2/ZBTB7A rescue\",\n      \"pmids\": [\"28270516\", \"29764865\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How Med26 recruitment is targeted to specific promoters unclear\", \"Breadth of direct oncogenic targets incompletely mapped\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Extended HP1\\u03b3 repression to disease-relevant targets and tissues, repressing Notch3 in vascular smooth muscle and FBP1 in pancreatic cancer, while a cardiomyocyte knockout revealed selective H4K20me3 dependence and HP1\\u03b2 compensation.\",\n      \"evidence\": \"VSMC overexpression with luciferase and carotid injury model; CBX3/FBP1 glycolysis rescue; CM-specific HP1\\u03b3 KO with chromatin-mark and transcriptome analysis; NGF-PKA S83 phosphorylation in PC12 cells\",\n      \"pmids\": [\"29206900\", \"29678579\", \"29665845\", \"30305677\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Tissue-specific selection of repressed targets not explained\", \"Compensation logic among HP1 isoforms not generalized\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Added a reversible negative regulator of chromatin binding, showing PAD4 citrullinates the chromodomain at R38/R39 to reduce H3K9me3 affinity and chromatin residence during ESC differentiation.\",\n      \"evidence\": \"In vitro citrullination with R38/R39 mutants, peptide binding, and live-cell single-particle tracking in mESCs\",\n      \"pmids\": [\"30940194\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Genome-wide consequences of citrullination not mapped\", \"Interplay with S83 phosphorylation untested\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Linked HP1\\u03b3 subcellular partitioning to tumor suppression, showing HPV E6/CRM-1-driven nuclear export relieves repression of UBE2L3 and destabilizes p53, while nuclear retention restores UBE2L3 silencing.\",\n      \"evidence\": \"Co-IP with exportin-1, NES mutagenesis, leptomycin B, ChIP at UBE2L3, and xenografts in cervical cancer cells\",\n      \"pmids\": [\"32203172\", \"32825184\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Signals governing constitutive nucleocytoplasmic balance unclear\", \"Cytoplasmic HP1\\u03b3 functions beyond sequestration not defined\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Established a reader-independent chromatin-maintenance role and RNA-based splicing mechanism: HP1\\u03b3 maintains genic H3K36me3 via NSD1 through its CSD/hinge, and binds intronic SINE RNA to safeguard splice-site selection.\",\n      \"evidence\": \"ChIP-seq with domain mutants and NSD1 Co-IP in ESCs; RIP-seq with motif identification and splicing analysis; CD8+ T-cell and TRIM28/TRIM24/RBBP4 complex studies\",\n      \"pmids\": [\"33237287\", \"34312949\", \"28220815\", \"34785774\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How RNA-binding and histone-reading activities are coordinated unresolved\", \"Determinants of NSD1 versus other effector engagement unknown\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Revealed acetylation-controlled stability and a direct role at replication forks, with HDAC1 K5 deacetylation protecting HP1\\u03b3 from degradation and PLK1-enhanced RB1 binding modulating CDK4/6 sensitivity.\",\n      \"evidence\": \"SILAC acetyl-proteomics, K5 mutagenesis, MDC1 Co-IP and ATAC-seq in myeloma; PLK1 kinase/RB1 Co-IP in CRPC; HP1\\u03b3-deficient MEF telomere/R-loop analysis\",\n      \"pmids\": [\"36894562\", \"37949681\", \"37598977\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Crosstalk between K5 acetylation and S83/S95 phosphorylation not integrated\", \"Telomere transcriptional control mechanism single-lab\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Defined HP1\\u03b3 control of replication-fork restart and immune/metabolic repression, with CK2-CDH1 degradation enabling fork restart and promoter binding silencing STAT1/PD-L1, CUL3, and lactylation/EP300-driven programs.\",\n      \"evidence\": \"RPA2 Co-IP, CK2 kinase, fork-restart and PARP-inhibitor assays; ChIP/KO mouse models for STAT1/CD274 and CUL3; CBX3-EP300 lactyl-CoA substrate assays\",\n      \"pmids\": [\"38781342\", \"38684864\", \"40089640\", \"39545414\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether fork-restart and transcriptional roles share regulatory cues unclear\", \"Direct versus indirect contribution to immune evasion targets not fully separated\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Provided structural and biophysical mechanisms for HP1\\u03b3 effector engagement, showing an antiparallel CSD dimer-of-dimers with KAP1 for unique cooperative repression and TRIM66-driven phase separation at H3K9me3.\",\n      \"evidence\": \"Crystallography/NMR/mass photometry of HP1\\u03b3CSD-KAP1 with KO-ESC rescue; PxVxL/LLPS reconstitution with TRIM66; SETDB1-CBX3 ChIP-reChIP at SIRT4\",\n      \"pmids\": [\"41575850\", \"40070663\", \"40197868\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional output of TRIM66\\u2013HP1\\u03b3 condensates in DNA damage not fully defined\", \"How antiparallel CSD architecture dictates target specificity untested\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"It remains unresolved how the many post-translational modifications (S83/S95 phosphorylation, K5 acetylation, R38/R39 citrullination) are integrated to coordinate HP1\\u03b3's parallel roles in elongation, splicing, repression, and fork restart, and what dictates target and isoform selection genome-wide.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No unified model linking modification state to functional output\", \"Genome-wide rules for direct repression-target selection unknown\", \"Interplay between RNA-binding and histone-reading activities mechanistically undefined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0042393\", \"supporting_discovery_ids\": [0, 11, 15, 20]},\n      {\"term_id\": \"GO:0003723\", \"supporting_discovery_ids\": [7, 24]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [17, 18, 33, 34]},\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [16, 23, 36]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [0, 38, 39]},\n      {\"term_id\": \"GO:0005694\", \"supporting_discovery_ids\": [8, 38]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [21, 39]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [0, 10, 33]},\n      {\"term_id\": \"R-HSA-8953854\", \"supporting_discovery_ids\": [7, 24]},\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [11, 23, 36]},\n      {\"term_id\": \"R-HSA-73894\", \"supporting_discovery_ids\": [28, 32]},\n      {\"term_id\": \"R-HSA-1640170\", \"supporting_discovery_ids\": [5, 13]}\n    ],\n    \"complexes\": [\"KAP1/TRIM28-HP1\\u03b3 complex\", \"TRIM28/TRIM24/RBBP4-CBX3 complex\", \"MSK1-HP1\\u03b3 complex\"],\n    \"partners\": [\"KAP1\", \"NSD1\", \"MED26\", \"RPA2\", \"MDC1\", \"TRIM66\", \"EP300\", \"BRCA1\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":8,"faith_total":8,"faith_pct":100.0}}